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2 Abstract 
 
Hematopoiesis - the generation of all mature blood cell types of the body - relies on 
tightly controlled lineage decision as cells differentiate from hematopoietic stem cells (HSCs) 
towards the different lineages. To a large part, lineage differentiation is controlled by 
hematopoietic cytokines. It was recently shown by continuous live cell imaging that the two 
cytokines M- and G-CSF, which in vivo are the principal regulators of monocyte/macrophage 
and granulocyte differentiation, respectively, can instruct the lineage choice of uncommitted 
bipotent granulocyte macrophage progenitors (GMPs).  
M- and G-CSF activate a multitude of signaling pathways that mediate their 
pleiotropic actions, which include survival, proliferation, and ultimately differentiation. 
However, the involvement of specific signaling pathways in controlling different cell fates 
remains poorly understood. Specifically, pathways orchestrating lineage choice instruction 
remain elusive. The M-CSF receptor (MCSFR) carries eight functional tyrosine residues that 
transmit M-CSF-evoked signaling. Studies on individual MCSFR tyrosine residue-activated 
signaling and its concomitant influence on cell fate have mainly relied on myeloid cell lines 
and/or MCSFR chimeras, often resulting in contradictory conclusions.   
In this study we established a system allowing the analysis of M-CSF-induced 
signaling in uncommitted primary progenitor cells. Combining MCSFR loss of function 
studies to dissect M-CSF-activated signaling pathways with novel bioimaging technologies 
allowing long-term quantification of single cell behavior, we investigated the molecular 
mechanism orchestrating M-CSF-instructed lineage differentiation. Our results show that 
MCSFR signals mediated by tyrosine residue 559 (Y559) are sufficient for macrophage 
differentiation from uncommitted progenitors and that overexpression of constitutively active 
members of the Src family of kinases (SFKs), which bind Y559, recapitulates this effect. 
Downstream of SFKs, we identify PI3K/Akt and NFκB signaling as putative mediators. 
Furthermore, we analyzed M- and G-CSF-induced gene expression during lineage 
commitment of GMPs and found that the overall response is surprisingly similar between the 
two different cytokines, suggesting that differentiation into macrophages and granulocytes is 
regulated by a small set of genes. 
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3 Introduction  
 
3.1 Hematopoiesis 
 
 Hematopoiesis is the tightly controlled process of constant regeneration of all mature 
blood and immune cells throughout life (Orkin & Zon 2008). This process starts from a rare 
population of mainly quiescent multipotent hematopoietic stem cells (HSCs), which 
predominantly resides in specialized microenvironments (niches) within the bone marrow 
(BM) (Schofield 1978, Wilson et al. 2008). A hallmark of HSCs, and stem cells in general, is 
their ability to self-renew, i.e. to generate progeny with HSC potential. It is believed that they 
may divide asymmetrically, giving rise to another HSC and a more differentiated multipotent 
progenitor (MPP) cell that has lost self-renewing capacity. MPPs differentiate towards the 
different hematopoietic lineages through several lineage-restricted progenitor populations, 
ultimately generating all the mature blood cell types. Because hematopoiesis is a process of 
step-wise loss of multipotency, it is often regarded as a relatively linear hierarchy with HSCs 
being on top and mature cells at the bottom. In vitro culture analyses, immunophenotyping, 
and experimental BM transplantations have led to the classical view of hematopoiesis, in 
which HSCs/MPPs either differentiate towards the lymphoid lineage (B-cells, T-cells, and 
natural killer (NK)-cells) through a common lymphoid progenitor (CLP) or towards the 
myeloid lineage (granulocytes (G), monocytes/macrophages (M), erythrocytes (E), 
megakaryocytes (Meg), and mast cells) through a common myeloid progenitor (CMP). 
Dendritic cells (DCs) can be of lymphoid or myeloid origin (Liu & Nussenzweig 2010). 
Many of the different multipotent progenitor populations have been immunophenotypically 
defined during the last decades and can now be prospectively isolated for functional studies 
using fluorescence activated cell sorting (FACS) (Figure 3-1). Due to improvement in FACS 
technology and the combinatorial use of surface markers along with stage- and/or lineage-
specific transgenic expression of reporter genes in mice, new sub-progenitor populations 
continue to be described, constantly refining and/or challenging the view of the 
developmental landscape of hematopoiesis. For example, the classical binary view of 
myeloid versus lymphoid branching has been challenged by the description of the lymphoid-
primed multipotent progenitor (LMPP) within the primitive lineage marker negative (linneg) 
Sca-1pos c-kitpos (LSK) fraction, which contains HSCs and MPPs. The LMPP is restricted to 
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the macrophage, T-cel, and B-cel lineage, but lacks MegE potential (Adolfsson et al. 2005), 
which implies that GM cels could be generated by two diferent means: through the classical 
CMP and the LMPP (Iwasaki & Akashi 2007). Subsequent studies reassessing the LMPP 
population suggested that LMPPs possess residual MegE potential in vivo (Forsberg et al. 
2006) yet not refuting the existence of true strictly GM-lymphoid commited progenitors 
(GMLPs). 
 
Figure 3-1: The hematopoietic lineage hierarchy.  
Al hematopoietic cels originate from self-renewing hematopoietic stem cels (HSCs), which progressively give 
rise to more commited downstream progenitors devoid of self-renewal. Ultimately, lineage-restricted 
progenitors generate the respective mature cels of their associated lineage. In the murine system, most 
hematopoietic stem and progenitor cels can be prospectively isolated using a combination of antibodies against 
the depicted cel surface markers. Note: some intermediate progenitor populations are not depicted. LT-HSC: 
long-term HSC; IT-HSC: intermediate term HSC; ST-HSC: short-term HSC; MPP: multipotent progenitor; 
LMPP: lymphoid primed multipotent progenitor; CLP: common lymphoid progenitor; ETP: early thymic 
progenitor; NK-cels: natural kiler cels; CMP: common myeloid progenitor; GMP: granulocyte macrophage 
progenitor; MEP: megakaryocyte erythroid progenitor; Lin: lineage marker; Flt3: fms-related tyrosine kinase 3; 
Sca1: stem cel antigen 1. Adapted from (Doulatov et al. 2012). 
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3.2 Myelopoiesis 
 
 Myelopoiesis, the production of cells belonging to the myeloid lineage, makes up the 
majority of hematopoiesis. For instance, 1-2 x 1011 neutrophils (a subset of granulocytes) 
have to be generated in a normal adult human per day (Dancey et al. 1976). This huge 
demand of cells is met with high proliferative potential of the intermediate multipotent 
progenitor populations rather than the mostly quiescent HSCs (Wilson et al. 2008), 
demonstrating that the progenitor pool has a significant level of control over mature blood 
cell production.  
 Cells of the monocyte/macrophage and granulocyte lineages are primarily responsible 
for innate immunity – the first line of defense against a variety of pathogens – and 
inflammatory responses. They are phagocytic cells, ingesting foreign material and organisms, 
and some can act as antigen presenting cells for lymphocytes.  
 Macrophages are large cells residing mainly in peripheral tissues (Wynn et al. 2013). 
They are responsible for tissue maintenance by engulfing cellular debris and apoptotic cells 
that result from tissue injury or remodeling (e.g. during development). Moreover, 
macrophages are involved in immune regulation by coordinating lymphocyte function 
through antigen presentation, cytokine secretion, and the recognition and ingestion of cellular 
pathogens. The prevalent view that all tissue-resident macrophages are derived from 
circulating monocytes has recently been challenged by lineage tracing experiments showing 
that macrophages in most tissues are derived from yolk sac or fetal liver progenitors 
(Ginhoux et al. 2010, Hoeffel et al. 2012, Schulz et al. 2012, Yona et al. 2013). 
 Granulocytes are a group of cells that can be subdivided into three classes: 
neutrophils, eosinophil, and basophils. Neutrophils, the predominant class of granulocytes, 
function in killing bacteria and fungi and are the main effectors of inflammatory responses 
(Borregaard 2010). Eosinophils are pro-inflammatory cells that tend to reside in tissues 
exposed to external environment such as skin, gastrointestinal tract, and lungs. Basophils are 
the least common type of granulocytes in peripheral blood and mediate allergic reactions. 
Mast cells, unlike mature granulocytes that are found in the peripheral blood and whose 
nuclei are segmented, do not have a segmented nucleus and do not complete maturation until 
they home to tissue. The developmental origin of mast cells is still under debate (see below). 
 Granulocytes and monocytes/macrophages arise from a common progenitor, the 
granulocyte macrophage progenitor (GMP). The differentiation of the myeloid lineage is 
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orchestrated through the coordinated integration of intrinsic and extrinsic signals through a 
network of complex and finely tuned regulatory pathways that results in an overall response 
and specific gene expression signatures, as will be discussed in detail below.   
 
 
3.2.1 The myeloid lineage 
 
 Soon after the identification of a progenitor population restricted to the lymphoid 
lineage, known as the CLP (Kondo et al. 1997), a myeloerythroid-restricted equivalent, the 
CMP, was described (Akashi et al. 2000). This population was identified within a population 
that lacks markers of mature blood cells (lineage negative), highly expresses c-kit (also 
known as CD117), and is negative for interleukin seven receptor alpha (IL7Rα) and stem cell 
antigen 1 (Sca-1). Based on expression of CD16/32 and CD34 this population can be further 
subfractioned into CMPs (CD16/32lo CD34pos), which were suggested to clonally give rise to 
both GMPs (CD16/32hi CD34pos) and megakaryocyte-erythroid progenitors (MEPs) 
(CD16/32neg/lo CD34neg) (Akashi et al. 2000). However, using the additional surface markers 
CD105 and CD150, recent studies showed that the CMP population largely consists of 
already lineage-segregated preGM and preMegE progenitors and that only very few cells 
clonally give rise to mixed myeloid populations (Pronk et al. 2007).  
GMPs mainly generate neutrophils and monocytes/macrophages but also dendritic 
cells, eosinophils, basophils, and mast cells, which collectively are effector cells cooperating 
in mounting a variety of allergic and innate immune responses. Progenitors restricted to 
respective lineages downstream of GMPs have been identified and prospectively isolated. 
Eosinophil-committed progenitors in the BM could be isolated based on interleukin 5 
receptor alpha (IL5Rα) expression (Iwasaki et al. 2005a), while a common basophil/mast cell 
progenitor was identified in the spleen based on the expression of ß7-integrin (Arinobu et al. 
2005). However, there is still debate on the true origin of mast cells: While some place them 
into the GM lineage (Arinobu et al. 2005), others argue that mast cells are generated 
independently of the GM lineage, but directly from MPPs (Chen et al. 2005, Franco et al. 
2010). Restricted basophil progenitors in the BM and mast cell progenitors mainly found in 
the intestine could be isolated using surface markers FcεR1α and FcγRII/III, respectively 
(Arinobu et al. 2005).  
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Likewise, downstream of GMPs, a population restricted to the M and DC lineages 
was identified using a Cx3cr1:GFP reporter mouse and consequently called macrophage 
dendritic cell progenitor (MDP) (Fogg et al. 2006). However, DCs can also be generated 
from lymphoid progenitors (Manz 2001). Downstream of the MDP, common DC progenitors 
have been identified (Liu et al. 2009, Naik et al. 2007, Onai et al. 2007), which give rise to 
classical DCs and plasmacytoid DCs but not monocytes. Recently, a Ly6Cpos 
monocyte/macrophage restricted progenitor was identified downstream of the MDP 
(Hettinger et al. 2013).  
 
 
3.2.2 Regulation of myeloid cell fate commitment 
 
 What are the factors influencing hematopoietic fate choice and what constitutes 
lineage commitment?  Lineage commitment of multipotent cells could be induced either by 
extrinsic factors such as cytokines and cell-cell interactions or by intrinsic mechanisms, 
including stochastic upregulation of transcription factors, microRNAs, or other regulatory 
molecules. Both extrinsic and intrinsic factors may actively induce lineage commitment 
(‘instruct’) or alternatively be permissive (‘select’) for one lineage. The instructive vs. 
selective model in orchestrating hematopoietic fate has been intensely debated, especially 
regarding the role of cytokines in this process. In the selective model, lineage commitment 
occurs independently of cytokines by a stochastic (i.e. random) process, such as spontaneous 
upregulation of a lineage-determining transcription factor. The cytokines’ function is then to 
provide survival and/or proliferation signals that select for a given lineage (Enver et al. 1998). 
Quite the opposite, instructive models postulate that cytokines actively drive multipotent cells 
toward a particular fate (Metcalf 1998). The instructive and selective models, which typically 
are regarded as competing models, will be discussed in more detail below.  
 
 
3.2.2.1 Stochastic gene expression in hematopoietic stem and progenitor cells (HSPCs) and 
its implications for lineage commitment  
 
As mentioned above, hematopoietic differentiation can be seen as a gradual loss of 
self-renewal potential and a stepwise acquisition of lineage identity. Thus, as HSCs 
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differentiate towards committed progenitors, one would expect an orchestrated activation of 
lineage-specific genes and simultaneous silencing of HSC-affiliated genes (e.g. genes 
involved in self-renewal). Vice versa, lineage-specific genes would be expected to be 
silenced in HSCs. However, these orderly gene expression patterns do not seem to be the rule 
in hematopoietic differentiation: Studies have shown that single multipotent cells express 
genes associated with divergent lineages at a low level compared to differentiated cells. 
Among them are genes encoding for transcription factors, cytokine receptors, and proteins 
having lineage-exclusive functions, such as globins and myeloperoxidase (Billia 2001, Hu et 
al. 1997, Månsson et al. 2007, Miyamoto et al. 2002). It is believed that this ‘lineage priming’ 
maintains differentiation flexibility of multipotent cells, before being specified into each 
lineage. However, the concept of lineage priming is founded almost exclusively on RNA 
expression data, which might equally reflect random gene expression noise with no 
functional relevance. 
Providing a mechanistic explanation for this apparently stochastic behavior of HSPCs, 
it has been proposed that low level expression of lineage-associated transcription factors may 
undergo random fluctuations, leading to self-reinforcing gene expression and stochastic 
lineage commitment (Chang et al. 2008, Cross & Enver 1997). A paradigmatic example for 
how such positive feedback loops in a metastable balance of cross-antagonistic transcription 
factors could lead to stable cell fate decisions is the transcription factor pair PU.1 and GATA-
1 (Enver et al. 2009, Graf & Enver 2009). MegE-affiliated GATA-1 and GM-affiliated PU.1 
regulate their own expression (Chen et al. 1995, Tsai et al. 1991) and inhibit each other’s 
transcriptional activity (Stopka et al. 2005, Zhang et al. 1999) (see below for details). 
Furthermore, it has been shown that forced expression of these factors can change lineage 
identity, demonstrating their potential to instruct lineage commitment (Heyworth et al. 2002, 
Nerlov & Graf 1998). Therefore, subtle changes in the balance of PU.1 and GATA-1 would 
lead to one of the factors’ downstream program being amplified, while the other factor’s 
program would be shut down, thereby instructing cells towards the GM (PU.1 up) or MegE 
(GATA-1 up) lineage. Similarly, it has been shown that the balance of transcription factors 
MafB and PU.1 is involved in controlling macrophage vs. dendritic cell fate (Bakri et al. 
2005). Levels of C/EBPα and PU.1 have been proposed to determine macrophage vs. 
granulocyte differentiation (see below) (Dahl et al. 2003). Integrating known positive and 
negative regulations of hematopoietic transcription factors into large networks has provided 
models on how cell fate decisions are executed and stabilized (Laslo et al. 2006, Moignard et 
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al. 2013, Palani & Sarkar 2009, Soneji et al. 2007). However, whether the cause of initial 
fluctuations in the metastable state of multipotent HSPCs is of stochastic origin or triggered 
by external cues (e.g. by cytokines) remains elusive, raising the question what role cytokines 
play in the lineage commitment process: Do they select or instruct lineage choice? 
 
 
3.2.2.2 Hematopoietic cytokines: selective vs. instructive functions 
 
Hematopoietic cytokines are small soluble regulators that are produced by a variety of 
different cell types. They include interleukins (ILs), colony stimulating factors (CSFs), 
interferons (IFNs), erythropoietin (EPO), and thrombopoietin (TPO). The CSFs, consisting of 
M-CSF, G-CSF, GM-CSF, and IL-3 (initially called multi-CSF), are a group of cytokines 
central to the differentiation of hematopoietic cells and will be discussed in more detail in 
section 3.3. Cytokines bind to and activate a family of structurally and functionally conserved 
cytokine receptors, eliciting pleiotropic biological responses in target cells. Since their 
discovery, cytokines have been known to stimulate survival and proliferation of HSPCs and 
to strongly influence their lineage outcome (Metcalf 2008). Yet, whether this results from a 
selective function on already committed cells, promoting their proliferation and survival, or 
from an instruction of lineage choice, has been under debate for decades (Figure 3-2) (Enver 
et al. 1998, Metcalf 1998).  
 
 
Studies supporting selective cytokine function 
 
In studies supporting the idea that fluctuations in transcription factor levels are the 
cause for lineage commitment, cytokine function is usually regarded as secondary, selectively 
allowing the amplification and survival of cells that upregulated cytokine receptors upon 
stochastic lineage commitment (Cross & Enver 1997). Indeed, there are numerous studies 
showing that cytokine receptors are under the transcriptional control of key transcription 
factors. GATA-1 has been shown to activate transcription of the EPO receptor (EPOR) (Zon 
et al. 1991), while PU.1 can activate the promoters of the cytokine receptors for M-CSF 
(MCSFR), Flt3L (Flt3), and in cooperation with C/EPBα the receptors for G-CSF (GCSFR) 
and GM-CSF (GMCSFR) (Carotta et al. 2010, Hohaus et al. 1995, Smith et al. 1996, Zhang 
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et al. 1994). However, these studies cannot rule out that the initial variation in gene 
expression level leading to lineage commitment is not stochastic but deterministic: The 
primed state of multipotent HSPCs could allow them to rapidly respond to external signals, 
leading to the same stable scenario via feedback mechanisms as through stochastic 
fluctuation.  
 
Figure 3-2: Models of hematopoietic lineage differentiation. 
In the instructive model, the lineage choice of uncommitted progenitor cells is directly influenced by cytokines, 
resulting in progeny belonging only to the instructed lineage. In the selective model, lineage choice occurs 
through random mechanisms (e.g. fluctuating transcription factor networks) independently of cytokines. The 
function of cytokines is subsequently to select for a specific lineage by selective survival signals, while cells 
randomly committed to other lineages die. Importantly, both models have the same in- and output and therefore 
cannot be distinguished by snapshot analyses. Figure taken from (Rieger & Schroeder 2009). 
 
Further data indicating selective cytokine function comes from mice deficient for 
cytokines or their receptors. In virtually all cases, loss of function of a single 
cytokine/receptor does not completely abrogate its associated lineage, although minor to 
severe reductions in progenitors and/or mature cells have been reported. This is true for mice 
deficient for M-CSF/MCSFR (Dai et al. 2002, Naito et al. 1991, Yoshida et al. 1990), G-
CSF/GCSFR (Lieschke et al. 1994, Liu et al. 1996), GM-CSF (Stanley et al. 1994), 
Flt3L/Flt3 (Mackarehtschian et al. 1995, McKenna et al. 2000), IL7/IL7R (Carvalho et al. 
2001, Miller et al. 2002), EPO (Lin et al. 1996, Wu et al. 1995), and TPO (De Sauvage et al. 
1996).  
Transgenic approaches with receptor chimeras consisting of extracellular and 
cytoplasmic domains of different receptors were also used to clarify the role of cytokines in 
lineage commitment. In a knock-in approach, the cytoplasmic domain of the GCSFR was 
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fused to the extracellular domain of c-Mpl (the receptor for TPO), creating mice bearing a 
chimeric receptor that binds TPO, but signals through GCSFR. These mice have normal 
megakaryocyte and platelet counts, demonstrating that the intracellular GCSFR part can 
functionally replace c-Mpl signaling in these mice. Moreover, granulocyte numbers are 
normal, collectively indicating GCSFR-mediated non-specific survival and/or proliferation 
signaling and arguing against a lineage-instructive function (Stoffel et al. 1999). A similar 
study created knock-in mice bearing a chimeric receptor consisting of the extracellular part of 
GCSFR and the cytoplasmic signaling domain of EPOR. These mice are able to support the 
production of morphologically mature neutrophils, and treatment with G-CSF does not affect 
the number of myeloid or erythroid progenitors in the BM, indicating that G-CSF-specific 
signaling is not required for granulocytic differentiation or lineage commitment and that 
EPOR signaling has unspecific survival and/or proliferation function (Semerad et al. 1999). 
Studies using bcl-2 overexpression as a mean to suppress apoptosis have shown that 
in the absence of cytokines, differentiation of a multipotent cell line (Fairbairn et al. 1993), T-
cell development in IL-7 deficient mice (Akashi et al. 1997), and development of 
monocyte/macrophages in M-CSF-deficient mice (Lagasse & Weissman 1997) can be 
rescued, again indicating an important role of cytokines for survival, but not for 
commitment/differentiation.  
Collectively, these studies have often concluded that lineage commitment can occur 
independently of cytokines, thus attributing cytokines only a selective function. However, in 
vivo studies investigating cytokine function have to be regarded with caution, as same 
lineages can be produced by several different cytokines, compensating for the deficiency of a 
single cytokine. Furthermore, alternative ligands may bind the receptor of the knocked out 
cytokine, as is the case with IL-34, which was discovered to bind the MCSFR (Lin et al. 
2008). Generally, the fact that lineage commitment can occur in absence of a cytokine, does 
not exclude that cytokines can have an instructive function on uncommitted cells.  
  
 
Studies supporting instructive cytokine function  
 
Support for an instructive role of cytokines comes from studies ectopically 
overexpressing cytokine receptors in cell types normally not expressing them and then 
exposing the cells to the respective cytokine. Overexpression of the GMCSFR alpha-chain 
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instructs myeloid lineage conversion of CLPs and pro-T cells, but not of pro-B cells and 
MEPs (Iwasaki-Arai et al. 2003, King et al. 2002, Kondo et al. 2000). Instruction of myeloid 
DC fate has been achieved by overexpressing Flt3 in MEPs (Onai et al. 2006). MCSFR 
expression instructs myeloid fate in pro-B, pro-T, and multipotent cell lines (Borzillo et al. 
1990, Bourette et al. 2007, Pawlak et al. 2000). Yet, in other similarly conducted studies, the 
overexpressed cytokine receptor only leads to a proliferative signal in absence of lineage 
conversion, as in the case of MCSFR expression in primary erythroid progenitor cells 
(McArthur et al. 1994) and EPOR expression in myeloid or multipotent progenitors 
(McArthur et al. 1995, Pharr et al. 1994). This indicates that the target cells’ cellular context - 
in terms of available intracellular signaling components, transcription factors, and other 
molecular components - might be relevant for the outcome of ectopic cytokine signaling.  
Proving or disproving cytokine-mediated lineage instruction on uncommitted cells 
and to distinguish it from stochastic lineage commitment followed by selective survival is 
technically demanding. It requires following the fates of uncommitted cells and their progeny 
over time until cells commit to one lineage. Initial studies therefore cultured individual GM 
colony forming cell (GM-CFC)-derived daughters in either M- or GM-CSF. Analysis of the 
downstream progeny compared with the estimation of lineage potential of input cells 
suggested an instructive function of these cytokines (Metcalf & Burgess 1982).  
More recently, time-lapse imaging at the single cell level was utilized to investigate if 
M- and G-CSF can instruct the lineage choice of bipotent GMPs. If progenitors in cultures 
containing only one cytokine would randomly commit to a lineage not supported by the 
cytokine, single daughter branches of pedigrees should discontinue due to the lack of survival 
signals, while other branches should differentiate towards the supported lineage. This would 
indicate a selective function of the cytokine. If the cytokine is instructive, all progeny of 
single progenitor cells should differentiate into the instructed lineage, without early apoptotic 
events of single daughter cells (Figure 3-2). It was shown that M- and G-CSF mainly follow 
the latter scenario, demonstrating that these factors can instruct lineage choice (Rieger et al. 
2009). Moreover, using PU.1 upregulation as a read out for myeloid commitment, it was 
recently suggested that M-CSF can instruct HSCs and that this is controlled by the 
transcription factor MafB (Mossadegh-Keller et al. 2013, Sarrazin et al. 2009).  
In summary, these studies indicate that some cytokines are able to instruct lineage 
choice, but that it is probably cell type and context dependent.  
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3.2.2.3 Myeloid transcription factors and mechanisms of lineage differentiation 
 
Regardless of whether one favors the selective or instructive model of cytokine 
function, it is evident that transcription factors play key roles in the determination of the 
ultimate cell fate of a differentiating cell by driving lineage-characteristic gene expression. 
The molecular basis of transcription factor-mediated lineage differentiation depends on 
protein levels, mutual antagonistic regulation of lineage-specific proteins, and the 
chromatin/epigenetic state of the cell. Two critical myeloid transcription factors are PU.1 and 
C/EBPα.  
PU.1 is a member of the large Ets family of transcription factors and is expressed at 
low levels in early HSPCs. As cells differentiate and mature, PU.1 expression is 
downregulated in the erythroid, megakaryocytic, and T-cell lineages, but increases in the 
monocytic, granulocytic, dendritic, and B-cell lineages (Carotta et al. 2010, Hromas et al. 
1993). Almost all myeloid-affiliated genes contain PU.1 binding sites in their promoters (e.g. 
those encoding  CD11b, MCSFR, GMCSFR, GCSFR) (Hohaus et al. 1995, Smith et al. 1996, 
Zhang et al. 1994). Mice deficient for PU.1 do not produce macrophages, granulocytes, or 
lymphoid cells during fetal hematopoiesis and die in late gestation or shortly after birth 
(McKercher et al. 1996, Scott et al. 1994). Conditional deletion of PU.1 in adult mice showed 
that adult PU.1-/- HSCs do not give rise to detectable CLPs, CMPs, or GMPs (Dakic et al. 
2005, Iwasaki et al. 2005b). Intriguingly, the most pronounced consequence of the 
conditional inactivation of PU.1 in adult mice is greatly expanded granulopoiesis, suggesting 
that expression of PU.1 restricts differentiation of GMPs into granulocytes (Dakic et al. 
2005). Furthermore, deletion of PU.1 leads to drastically reduced differentiation of dendritic 
cells (Carotta et al. 2010). Overexpression of PU.1 activates myeloid gene expression and 
causes irreversible myeloid differentiation with concomitant suppression of other lineage 
fates (Nerlov & Graf 1998).  
The mechanism by which PU.1 specifies the GMP from the CMP and/or the LMPP 
from the MPP is believed to involve antagonizing the function of GATA-1. GATA-1 is a zinc 
finger transcription factor expressed in the erythroid, megakaryocytic, mast cell, and 
eosinophilic lineage and their progenitors (Martin et al. 1990, Zon et al. 1993). Mice deficient 
for GATA-1 show a block in erythroid and megakaryocyte development (Pevny et al. 1991, 
Shivdasani et al. 1997). Forced expression of GATA-1 in GM committed primary cells 
reprograms them into the MegE lineage, while inhibiting normal GM differentiation 
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(Heyworth et al. 2002). PU.1 and GATA-1 can bind to each other and thereby antagonize 
each other’s transcriptional activity. PU.1 does so by recruiting the retinoblastoma (Rb) 
protein to GATA-1, which in turn leads to recruitment of a transcriptional repression complex 
(Rekhtman et al. 2003, Stopka et al. 2005). Conversely, GATA-1 can bind to the DNA-
binding domain of PU.1, displacing the critical coactivator c-Jun and thereby decreasing 
PU.1-mediated transcription (Zhang et al. 1999). Furthermore, both GATA-1 and PU.1 
upregulate their own expression (Chen et al. 1995, Tsai et al. 1991).  
C/EBPα is a basic leucine zipper (bZip) transcription factor, which functions either as 
homo- or heterodimer. C/EBPα is expressed predominantly in the granulocytic and 
monocytic lineages and their precursors (Scott et al. 1992). Mice lacking C/EBPα have no 
granulopoiesis, impaired monopoiesis, and a decrease in GMP frequency (Heath et al. 2004, 
Zhang et al. 1997). In line with this, conditional deletion of C/EBPα in adult mice results in 
block of the CMP to GMP transition (Zhang et al. 2004). In fetal livers of C/EBPα-/- mice, 
erythroid development is significantly increased, and forced expression of C/EBPα in 
primary MEPs and an erythroleukemic cell line promotes myeloid over erythroid 
differentiation (Suh et al. 2006), suggesting a role of C/EBPα in the GM vs. MegE lineage 
choice. Forced expression of C/EBPα in a bipotential cell line of myeloid origin leads to 
granulocytic differentiation and suppression of the monocytic differentiation program 
(Radomska et al. 1998). Intriguingly, using CLPs, MEPs, B-cells, or pre-T cells, several 
studies have shown that overexpression of C/EBPα (and in some studies C/EBPß) in these 
cells leads to macrophage rather than granulocyte transdifferentiation (Fukuchi et al. 2006, 
Laiosa et al. 2006, Xie et al. 2004). These different lineage outcomes might depend on 
varying C/EBPα interaction partners present in the target cells.  In line with this, mutations in 
the leucine zipper domain of bZip proteins that allow controlling the partnering of bZip 
proteins showed that different C/EBPα heterodimers have distinct effects on hematopoietic 
differentiation when expressed in hematopoietic progenitors (Cai et al. 2008). While 
homodimers of C/EBPα only modestly increase monocyte differentiation, heterodimers of 
C/EBPα and c-Jun are potent in doing so. This suggests that different bZip interaction 
partners of C/EBPα might control monocytic vs. granulocytic cell fate. Depending on which 
C/EBPα interaction partners are available in the target cells used, overexpression of C/EBPα 
might then either lead to granulocytic or monocytic differentiation.  
Moreover, it was shown that the amount of PU.1 directs lineage outcome: High 
concentrations of PU.1 leads to monocytic rather than to granulocytic differentiation and vice 
____________________________________Introduction____________________________________ 
13 
 
versa in a PU.1-/- cell line, in which PU.1 activity was restored by introducing a 4-hydroxy-
tamoxifen(OHT)-inducible and -tunable PU.1-ER fusion (PUER cell line) (Dahl et al. 2003). 
This was suggested to be regulated by the PU.1 vs. C/EBPα ratio. Consistent with this 
hypothesis, it was shown that C/EBPα can bind PU.1 leading to dissociation of c-Jun and 
blocking PU.1 transactivation (Reddy et al. 2002). However, a converse mechanism of PU.1 
directly antagonizing C/EBPα has not been described and might be regulated through further 
downstream factors.  
Analyzing the transcriptomes of single cells after activating PU.1 using the above 
mentioned 4-OHT-inducible cell line showed that the transcriptional regulators Egr-2 and 
Nab-2 are upregulated within 24 hours of PU.1 activation and remain expressed during 
monocyte differentiation (Laslo et al. 2006). Egr-2 and Nab-2 form a repressive transcription 
complex, which was shown to mediate repression of granulocyte-affiliated genes and 
simultaneously activate macrophage-associated genes, such as the one encoding the MCSFR 
(Krysinska et al. 2007, Laslo et al. 2006). Furthermore, Egr-1 was shown to induce 
monocytic differentiation at the expense of granulocytes in vivo (Krishnaraju et al. 2001). A 
candidate for a transcription factor that inhibits the expression of macrophage-associated 
genes and promotes granulocytic gene expression is Gfi-1. Gfi-1 deficient mice are severely 
neutropenic (Hock et al. 2003, Karsunky et al. 2002) and Gfi-1 overexpression in progenitors 
directs granulocytic differentiation at the expense of macrophages through direct interaction 
with and repression of PU.1 (Dahl et al. 2007). Differentiation of PUER cells into 
macrophages is accompanied by downregulation of Gfi1, and Egr-2 and Nab-2 were shown 
to directly bind the Gfi1 promoter to repress its transcription. Conversely, forced expression 
of Gfi1 in PUER cells inhibits differentiation into macrophages and decreases expression of 
Egr-2 (Laslo et al. 2006). A model was suggested, in which PU.1 and C/EBPα are primary 
cell-fate determinants that upregulate Egr-2/Nab-2 and Gfi1, respectively. Cross-antagonism 
between Egr-2/Nab-2 and Gfi1 then stabilizes a tilted PU.1:C/EBPα ratio, leading to either 
macrophage differentiation in the case of dominant PU.1 or granulocyte differentiation in the 
case of dominant C/EBPα.  
Collectively, these studies demonstrate the important role of transcription factors in 
stabilizing lineage decisions by executing lineage-specific gene expression programs, which 
lead to lineage differentiation. However, whether the initial upregulation of transcription 
factors is based on their randomly fluctuating expression levels or on external cues remains 
unknown. Similarly, signaling pathways induced by external cues and potentially involved in 
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activating already present lineage-specific transcription factors in HSCPs are also not well 
described. 
 
  
3.2.2.4 Epigenetic regulation of hematopoietic differentiation 
 
 Expression of lineage-specific gene programs requires more than the availability of 
the necessary transcription factors. The accessibility of genes to transcription factors and 
other regulatory proteins is regulated through chromatin modifications, such as acetylation, 
methylation, phosphorylation, ubiquitination, and other collectively termed epigenetic 
modifications. As cells differentiate, chromatin remodeling occurs until an irreversible state 
is achieved that is specific for a terminally differentiated lineage. Recently, comprehensive 
DNA methylation maps for different HSCPs have been provided, revealing lineage-specific 
programs of DNA methylation changes during hematopoietic differentiation (Ji et al. 2010). 
Moreover, DNMT1, a DNA methyltransferase, was shown to be important for HSC self-
renewal and commitment to lymphoid vs. myeloid differentiation (Bröske et al. 2009, 
Trowbridge et al. 2009). Identification of genome-wide changes in gene expression and 
histone modifications during hematopoiesis revealed that developmentally regulated genes 
are epigenetically primed in HSCs for subsequent activation or repression during lineage 
commitment (Cui et al. 2009, Weishaupt et al. 2010). Furthermore, transcription factors such 
as GATA-1 themselves bind factors that can induce epigenetic changes (Blobel 2002, 
Gregory et al. 2010, Miccio et al. 2010). 
 
 
3.2.2.5 miRNAs in myeloid development 
 
 An emerging group of putative lineage determinants are microRNAs (miRNAs), 
small non-coding regulatory RNA molecules that bind target sequences in messenger RNA 
(mRNA), thereby inhibiting their expression either by induction of their degradation or by 
inhibition of their translation. Most miRNAs exerting effects on myelopoiesis were 
discovered by profiling studies, revealing that many miRNAs are expressed at various stages 
of myeloid development. Several miRNAs have now been analyzed in gain and loss of 
function studies and are confirmed as being important in myeloid biology. It has been shown 
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that several myeloid transcription factors can induce the expression of miRNAs, thereby 
changing the transcriptional profile of a cell.  
 miR-223 was one of the first miRNAs to be discovered to be highly expressed in 
myeloid cells and was later attributed a functional role in myelopoiesis itself (Chen et al. 
2004). Specifically, miR-223 is highly expressed in granulocytes and its expression is 
becoming incrementally higher with granulocytic maturation. Loss of miR-223 results in an 
expanded granulocyte compartment and to neutrophilic hypersensitivity in response to 
activating stimuli (Johnnidis et al. 2008). Expression of miR-223 is regulated by several 
factors, including C/EBPα and PU.1 (Fazi et al. 2005, Fukao et al. 2007). Increasing levels of 
C/EBPα during granulocytic differentiation competitively displaces the transcriptional 
repressor NFI-A from the miR-223 promoter and induces miR-223 expression. This 
molecular switch leads to a negative feedback loop in which miR-223 represses NFI-A 
translation, which enables exit from the progenitor cell state and initiates granulocytic 
differentiation (Fazi et al. 2005). Interestingly, it was shown that during macrophage 
differentiation PU.1 induces expression of miR-424, which also targets NFI-A, and that this 
is necessary to induce differentiation-specific genes including the MCSFR gene (Rosa et al. 
2007). This suggests that NFI-A is a key transcription factor required in maintaining myeloid 
progenitors in an undifferentiated state. C/EBPα and PU.1 each induce distinct miRNAs, 
which can downregulate NFI-A expression, leading to the onset of either macrophage or 
granulocyte differentiation.  
 M-CSF signaling was shown to induce expression of the transcription factor AML1 
and repress the expression of miR-17-5p-20a, which was demonstrated to regulate AML1 
protein expression by targeting the AML1 mRNA. This leads to a positive feedback loop 
resulting in the accumulation of AML1 protein and MCSFR expression (Fontana et al. 2007). 
 Other examples of miRNAs involved in myeloid development include miR-146a, 
whose deletion eventually causes an overproduction of myeloid cells (Boldin et al. 2011). 
Overexpression of miR-155, miR-29a, or miR-125b in BM all result in a bias towards the 
GM lineage, suggesting that these miRNAs are involved in the regulation of the lymphoid vs. 
myeloid balance (Bousquet et al. 2010, Han et al. 2010, O’Connell et al. 2008).   
 It has become evident in recent years that miRNAs are also involved in modulating 
signal transduction pathways. For example, it has been shown that miR-21 and miR-126 
target inhibitors of phosphatidylinositide 3 kinase (PI3K) and mitogen-activated protein 
kinase (MAPK) cascades, thereby leading to the upregulation of these signaling pathways 
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(Fish et al. 2008, Thum et al. 2008). Similarly, miR-24 has been found to repress MKP-7, a 
negative regulator upstream of the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling 
cascades. Overexpression of miR-24 in myeloid progenitor cells results in enhanced MAPK 
activation and a developmental block in granulocytic differentiation (Zaidi et al. 2009). 
 Collectively, these studies suggest that miRNAs might play an important role in 
lineage outcome through regulation and fine-tuning of lineage-specific gene expression and 
growth factor-induced signaling pathways.    
 
 
 
3.3 The colony stimulating factors M-CSF and G-CSF and their receptors: function 
and regulation of myeloid differentiation  
 
 As mentioned earlier, the CSFs are a group of cytokines central to hematopoiesis, the 
modulation of specific blood cells’ functional responses, and overall immune competence. 
This group consists of M-CSF and G-CSF, which exert lineage-specific functions, playing a 
role in the survival, proliferation, and differentiation of macrophages and granulocytes, 
respectively, and their progenitors, and GM-CSF and IL3 (also called multi-CSF), which 
regulate the expansion and maturation of more primitive multipotent progenitors. Production 
and degradation of CSFs are strictly controlled and so is their expression and that of their 
cognate receptors, allowing their coordinated biological function during homeostasis and 
stress conditions. All CSFs exhibit pleiotropic biological functions on various tissues and 
cells and show extensive functional redundancy, being able to exert similar or overlapping 
actions on specific cells (Figure 3-3). 
 The identification and analysis of the CSFs was made possible primarily by cell 
culture assays developed from the 1960s to early 1980s (Bradley & Metcalf 1966, Ichikawa 
et al. 1966, Metcalf & Burgess 1982). These assays in semi-solid medium revealed the 
biological factor-dependent survival, proliferation, and differentiation of immature 
hematopoietic cells (colony forming units) and led to the subsequent purifications of CSFs.  
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Figure 3-3: Pleiotropic actions of a single cytokine orchestrate lineage diferentiation. 
Single cytokines can have multiple efects on cels carrying the cognate receptor. The net effect of these 
cytokine-mediated actions is diferentiation towards a specific lineage. Discontinuous analyses cannot detect 
and/or quantify the contribution of the different cytokine-mediated cel fate effects on differentiation. 
 
 
3.3.1 M-CSF 
 
M-CSF (also known as CSF-1) was the first CSF to be purified (Stanley & Heard 
1977) and was originaly found in murine serum and human urine (Bradley et al. 1967, 
Robinson et al. 1969). M-CSF is a homodimeric sialoglycoprotein and acts as the principal 
regulator of the survival, proliferation, and diferentiation of monocyte/macrophages and 
their precursors. M-CSF is also a key regulator of mature macrophages, mediating their 
functional activation and celular behavior (Pixley & Stanley 2004). M-CSF can synergize 
with other cytokines, such as IL-6, to induce proliferation of early hematopoietic progenitors 
(Bot et al. 1989). M-CSF also synergizes with receptor activator of nuclear factor kappa-B 
ligand (RANKL) to induce osteoclastogenesis (Teitelbaum & Ross 2003). A variety of 
diferent cel types can produce and secrete M-CSF. These include endothelial cels, BM 
stromal cels, fibroblasts, osteoblasts, thymic epithelial cels, keratinocytes, astrocytes, 
myoblasts, and others. M-CSF production can also be stimulated in monocytes/macrophages, 
T-cels, B-cels, chondrocytes, and other cel types upon their functional activation through, 
for example, inflammatory cytokines. In addition to two secreted forms of M-CSF, there is 
also a membrane-spanning form at the cel surface, which is produced by alternative splicing 
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(Rettenmier & Roussel 1987). Transgenic expression of the different M-CSF isoforms in M-
CSF-deficient mice revealed distinct, but overlapping functions: While the secreted 
glycoprotein isoform humorally regulates cellular targets, the membrane-bound and the 
secreted proteoglycan isoforms are suggested to be involved in local regulation (Dai et al. 
2004, Nandi et al. 2006, Ryan et al. 2001). The main mechanism to negatively regulate M-
CSF activity is through internalization and degradation of ligand-receptor complexes by cells 
expressing the MCSFR (Bartocci et al. 1987). 
The overall biological response of cells to M-CSF is dependent on cell types and co-
stimulating signals from additional extracellular or intracellular events. Although cells of the 
monocytic lineage are considered the main target population, the action of M-CSF is not 
limited to these cells, as reflected by M-CSF-deficient mice. M-CSF deficiency in mice 
carrying a null-mutation in the coding region of the M-CSF gene (op/op mice) leads to a 
severe reduction of osteoclasts and macrophages, absence of teeth, abnormal bone 
remodeling and osteopetrosis, abnormal breast and brain development, decreased fertility, 
and an overall shortened life-span (Michaelson et al. 1996, Pollard & Hennighausen 1994, 
Wiktor-Jedrzejczak & Gordon 1996, Yoshida et al. 1990). Many of these defects can be 
rescued by injection of recombinant M-CSF into neonatal mice (Wiktor-Jedrzejczak et al. 
1991).  
  
 
3.3.2 M-CSF receptor structure/function 
 
The effects of M-CSF are mediated through the MCSFR (also known as CD115), a 
member of the class III receptor tyrosine kinases, also including c-kit, Flt3, and the PDGF 
receptor (Sherr et al. 1985). The MCSFR has an N-terminal glycosylated extracellular part 
containing five immunoglobulin-like domains, a short single transmembrane domain, a 
juxtamembrane domain, and a split kinase domain in the C-terminal cytoplasmic portion. 
Binding of M-CSF promotes receptor dimerization and activation of the intrinsic tyrosine 
kinase activity, leading to transphosphorylation of specific tyrosine residues in the 
intracellular part of the receptor (Bourette & Rohrschneider 2000). The phosphorylated 
tyrosine residues then act as docking sites for a variety of intracellular adaptor proteins 
containing src-homology 2 (SH2) domains. This leads to activation of downstream signaling 
pathways and eventual cellular response, in form of cytoskeletal remodeling and increased 
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adhesion, as well as increased transcription and translation required for growth, proliferation, 
and differentiation. Stimulation of downstream signaling cascades is followed by 
polyubiquitination of the cytoplasmic MCSFR domain, kinase inactivation, tyrosine 
dephosphorylation, internalization, targeting to lysosomes, and destruction of the receptor-
ligand complex (Pixley & Stanley 2004).  
MCSFR-deficient mice show a more severe phenotype than op/op mice, with further 
reduction in tissue macrophage numbers, reduced survival, and increased osteopetrosis (Dai 
et al. 2002). This suggested that there is another MCSFR ligand, which was recently 
identified as IL34 (Lin et al. 2008). M-CSF and IL34 expression in embryonic and adult 
mouse tissues revealed different spatiotemporal expression patters. Most notably, IL34 is 
expressed early in the brain, when MCSFR, but no M-CSF expression is apparent (Nandi et 
al. 2012, Wei et al. 2010). IL-34-deficient mice selectively lack Langerhans cells and 
microglia, which are present in op/op mice, but absent in MCSFR-/- mice (Wang et al. 2012b). 
Of the 19 tyrosines in the cytoplasmic portion of the MCSFR, six (Y559, Y697, 
Y706, Y721, Y807, Y974) have been shown to be phosphorylated upon M-CSF stimulation 
(Tapley et al. 1990, van der Geer & Hunter 1990, Wilhelmsen et al. 2002). Two more 
tyrosines (Y544 and Y921) have been demonstrated to be phosphorylated in the 
constitutively active, oncogenic form of the MCSFR (Joos et al. 1996, Mancini et al. 1997). 
As mentioned above, most of the phosphorylated tyrosine residues form docking sites for 
signaling proteins that initiate a series of signaling cascades, which results in specific gene 
expression and cellular responses (Figure 3-4). Studies examining the role of individual 
receptor tyrosine residues in initiating specific signaling pathways and how these are 
connected to cellular fates have produced conflicting results depending on the cellular system 
and methods used. Nevertheless, despite their limitations, ectopic and chimeric MCSFR 
expression studies have provided significant functional knowledge about single MCSFR 
tyrosine residues and their associated signaling molecules.  
The juxtamembrane region of the MCSFR harbors Y544 and Y559. Y544 has so far 
not been demonstrated to be phosphorylated in the wild type receptor but only in the 
oncogenic form, where it binds an as yet unidentified protein of 55k-Da in size (Joos et al. 
1996). Y559 has been shown to bind Src family kinases (SFKs) when phosphorylated (Rohde 
et al. 2004). Furthermore, Y559 was shown to participate in autoinhibition of the MCSFR in 
absence of M-CSF: Mutation of Y559 significantly reduces receptor tyrosine phosphorylation 
and inhibits its kinase activity. This was observed in several cellular systems, including a 
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mature macrophage cell line (Xiong et al. 2011, Yu et al. 2012), a myeloid progenitor cell 
line (Rohde et al. 2004), and as a chimeric receptor in primary macrophages (Takeshita et al. 
2007). Phosphorylated Y559 activates a SFK and c-Cbl dependent pathway that leads to 
MCSFR ubiquitination and possibly to a further change in conformation, permitting increased 
receptor phosphorylation (Xiong et al. 2011). Therefore, Y559 seems to be a critical tyrosine 
residue inducing MCSFR phosphorylation and activation. However, which particular SFK 
associates with Y559 is still unknown. There are at least six SFKs expressed in macrophages: 
Hck, Fgr, Lyn, Src, Fyn, and Lck (Yu et al. 2012). Association of MCSFR with Src, Fyn, and 
Yes was demonstrated in transduced NIH3T3 fibroblasts or myeloid cell lines using GST-
SH2 pulldown assays (Courtneidge et al. 1993, Marks et al. 1999, Rohde et al. 2004). There 
are several contradictory reports on the cellular consequences if Y559 is mutated. Analyzing 
the effects of mutated Y559 in a myeloblastic leukemia cell line suggested that Y559 is not 
required for M-CSF-mediated proliferation (Marks et al. 1999). However, expressing the 
same mutant in another myeloblast-like cell line results in a hyperproliferative response to M-
CSF (Rohde et al. 2004). In contrast, expressing Y559-mutated MCSFR in primary 
macrophages substantially reduces proliferation (Takeshita et al. 2007, Yu et al. 2008). These 
contradicting results exemplify the importance of studying M-CSF responses in primary cells 
of interest rather than in cell lines. 
The split kinase insert of the MCSFR harbors three tyrosine residues phosphorylated 
upon M-CSF stimulation: Y697, Y706, and Y721. Phospho-Y697 binds growth factor 
receptor-bound protein 2 (Grb2), monocytic adaptor (Mona), and suppressor of cytokine 
signaling (SOCS)1 (Bourette et al. 1998, 2001; Geer et al. 1993). Grb2 is an adaptor protein 
known to bridge receptor tyrosine kinases to the Ras/Raf/MEK/ERK MAPK signaling 
cascade. MAPK signaling regulates many fundamental processes including survival, 
proliferation, differentiation, and cellular behavior. ERK targets include transcription factors 
such as c-fos, c-jun, and c-myc which mediate transcription of early M-CSF response genes 
(e.g. cell cycle genes). Hematopoietic-specific protein Mona was also described to activate 
the MAPK pathway and thereby induce monocyte differentiation in a myeloid progenitor cell 
line (Bourgin et al. 2000). SOCS1 is a known negative regulator of cytokine signaling and 
has been shown to downregulate M-CSF-mediated proliferation (Bourette et al. 2001). 
Mutation of Y697, however, shows only a mild defect on proliferation of primary 
macrophages transduced with a chimeric receptor (Faccio et al. 2007). Likely, this is because 
other phosphorylated tyrosine residues can also bind Grb2 (Y921) and SOCS1 (Y721) and 
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thereby compensate Y697 mutation (Bourette et al. 2001, Mancini et al. 1997). In line with 
this, combined mutation of Y697 and Y921 greatly accentuates the proliferative defect as 
compared to the single Y697 mutation (Faccio et al. 2007), further suggesting that Y921 may 
also be phosphorylated in the wild type receptor and not only in the oncogenic form. 
Phosphorylated Y706 has so far not been shown to directly bind signaling molecules. 
However, it has been shown that phospho-Y706 is required for full activation of  signal 
transducer and activator of transcription (STAT)1 (Novak et al. 1996). The most important 
function of Y721 is to activate PI3K signaling via binding of PI3K’s catalytic subunit p85, 
resulting in production of phosphatidylinositol (3,4,5) trisphosphate (PIP3) (Reedijk et al. 
1992, Sampaio et al. 2011). Many of the immediate M-CSF-induced cytoskeletal changes 
(e.g. membrane ruffling) in mature macrophages are regulated through Y721-mediated PI3K 
activation and subsequent PIP3 production (Sampaio et al. 2011). Small GTPases including 
Rac, RhoA, and cdc42 act downstream of PI3K to induce M-CSF-mediated cytoskeletal 
remodeling and motility (Pixley 2012). Immortalized macrophages carrying MCSFR mutated 
at Y721 exhibit significantly reduced adhesion, spreading, and mobility (Sampaio et al. 
2011). PIP3 production also activates Akt, which can trigger a multitude of downstream 
effectors involved in cell survival, proliferation, and motility. Activation of PI3K has also 
been shown to occur through SFKs bound to phosphorylated Y559 or c-Cbl bound to 
phospho-Y974. Using yeast two hybrid screening, phospho-Y721 was also found to bind 
phospholipase Cγ2 (PLCγ2) in a myeloid progenitor cell line (Bourette et al. 1997). However, 
in a mature macrophage context, PLCγ2 binding to MCSFR was shown to be independent of 
Y721 (Sampaio et al. 2011). SOCS1, besides binding Y697, has also been shown to associate 
with Y721 when phosphorylated (Yu et al. 2008). 
Y807, located in the MCSFR activation loop, has been implicated in MCSFR function 
along with Y559 (Takeshita et al. 2007, Yu et al. 2008). To date, no protein has been 
described to directly interact with activated Y807. In macrophages carrying a mutated Y807 
MCSFR, receptor phosphorylation is severely affected, suggesting an autoinhibitory role for 
this residue in MCSFR activity in absence of M-CSF. Using a rat-derived fibroblast cell line, 
it was shown that mutation of Y807 reduces the proliferative response to M-CSF (van der 
Geer & Hunter 1991). In contrast, the same mutant expressed in an immature myeloid cell 
line increases proliferation of these cells in the presence of M-CSF (Bourette et al. 1995). Yet 
another study analyzed the Y807mutant in primary macrophages using a receptor chimera 
consisting of the extracellular part of the EPOR and the cytoplasmic part of the MCSFR. This 
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study found that mutation of Y807 suppresses M-CSF-mediated macrophage proliferation 
(Takeshita et al. 2007). These studies further demonstrate the importance of studying M-CSF-
elicited efects in a corect celular context. 
  
 
Figure 3-4: Major MCSFR-activated signaling pathways. 
The MCSFR has eight functional tyrosine residues that upon binding of M-CSF to the receptor are 
transphosphorylated and subsequently act as docking sites for a number of SH2-containing adaptor proteins. As 
a result, a variety of diferent downstream signaling pathways are activated that mediate the pleiotropic actions 
of M-CSF. How each signaling pathway contributes to the effects elicited by M-CSF is not wel understood. 
SOCS: suppressor of cytokine signaling; FMIP: fms-interacting protein; SFK: Src family kinases; Grb: Growth 
factor receptor-bound protein; STAT: signal transducer and activator of transcription; Gab: GRB2-associated-
binding protein; PIP3: phosphatidylinositol (3,4,5)-triphosphate; DAG: diacylglycerol; Syk: spleen tyrosine 
kinase; SHIP: Src homology region 2 domain-containing inositol 5'-phosphatase; IKK: I kappa B kinase; PTEN: 
phosphatase and tensin homolog; PKC: protein kinase C; SHP: Src homology region 2 domain-containing 
phosphatase; MEK: mitogen-activated kinase kinase; ERK: Extracelular signal-regulated kinase; JNK: c-Jun N-
terminal kinase; Mona: monocytic adapter; SOS: son of sevenless; Shc: Src homology 2 domain containing 
protein. 
 
  The C-terminus of the receptor caries two more tyrosines: Y921 and Y974. As 
mentioned above, Y921 is mainly associated with the oncogenic form of MCSFR, where it 
was found to bind Grb2 when phosphorylated (Mancini et al. 1997). Y974 is associated with 
the E3 ubiquitin ligase c-Cbl, which ubiquitinates MCSFR (and receptor tyrosine kinases in 
general) and targets it for degradation (Mancini et al. 2002, Wilhelmsen et al. 2002). 
However, c-Cbl can also be indirectly activated through the Y559-SFK and Y721-PI3K axes. 
Additionaly, c-Cbl is required for ful phosphorylation and activation of the receptor (Xiong 
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et al. 2011). Another protein interacting with MCSFR, fms-interacting protein (FMIP) (also 
known as THOC5), has not been associated with a specific tyrosine residue yet, and its 
specific role in MCSFR signaling remains to be elucidated (Carney et al. 2009, Mancini et al. 
2004, Tamura et al. 1999).   
 Mutation of all eight tyrosines discussed above has been shown to result in a receptor 
incapable to transmit survival and/or differentiation cues (Yu et al. 2008). Other tyrosine, 
serine, or threonine residues phosphorylated in the MCSFR and activating other signaling 
pathways cannot be excluded to have additional functions but have so far not been described.  
 
 
3.3.3 G-CSF 
 
G-CSF is central to differentiation, proliferation, survival, and functional activation of 
granulocytes, of which relatively short-lived neutrophils are the most abundant. It was first 
purified from murine lung-conditioned medium (Nicola & Metcalf 1983). G-CSF can be 
generated by a variety of cells and production can be triggered under stress conditions by 
several cytokines, including IL-3, IL-17, GM-CSF, M-CSF, tumor necrosis factor alpha 
(TNF-α), and IFN-γ, which can lead to a dramatic increase in G-CSF concentration and up to 
a 10-fold increase in neutrophil number. Because of its effects on the modulation of 
granulocyte production and its ability to mobilize HSCs from the BM to circulation, G-CSF 
is being used clinically as a therapeutic agent. Furthermore, G-CSF treatment accelerates 
hematopoietic recovery after transplantation and chemotherapy and ameliorates neutropenia 
in patients with severe congenital or chronic neutropenia. Unlike M-CSF, excess G-CSF level 
has relatively few negative side effects, as shown in mice (Chang et al. 1989). Mice deficient 
for G-CSF or the GCSFR have a marked decrease in peripheral blood neutrophil counts (15-
30% of wild type mice), as well as a significant decrease of progenitors and mature 
granulocytes in the BM (Lieschke et al. 1994, Liu et al. 1996). As a result, G-CSF-/- mice are 
significantly impaired in fighting infections. Similarly to M-CSF, circulating G-CSF is 
actively cleared by ligand-receptor internalization and degradation (Ericson et al. 1997). 
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3.3.4 G-CSF receptor structure/function 
 
 The GCSFR is a member of the type I cytokine receptors. Unlike the MCSFR, the 
GCSFR does not have an intrinsic tyrosine kinase domain, but relies on cytoplasmic kinases 
for activation of downstream signaling pathways. The GCSFR is primarily expressed in 
granulocytic progenitors and mature neutrophils, but can also be found on other 
hematopoietic (Nicola & Metcalf 1985) and non-hematopoietic cells, including neurons 
(Schneider et al. 2005). It consists of an extracellular portion that harbors a conserved 
cytokine receptor homologous (CRH) domain, an Ig-like domain, and three fibronectin type 
III-like domains. The transmembrane domain is followed by a cytoplasmic domain 
containing two regions of sequence homology shared with other cytokine receptors and 
referred to as Box 1 and Box 2. Moreover, the cytoplasmic domain contains a more distal 
Box 3 motif and four functional tyrosine residues (Y703, Y728, Y743 and Y763). Upon G-
CSF binding, GCSFR homodimerizes and receptor-associated Janus protein tyrosine kinases 
(JAKs) undergo trans-phosphorylation and full kinase activation. JAKs in turn phosphorylate 
the four functional tyrosine residues of the receptor, which recruit intracellular SH2-
containing proteins to mediate downstream signaling (Figure 3-5).  
Early structure/function studies of the GCSFR revealed that the cytoplasmic portion 
contained regions with distinct signaling functions. The membrane-proximal region, 
including the Box 1 and 2 motifs required for JAK binding, is essential for G-CSF-induced 
proliferation, while the distal region containing the four functional tyrosines and the Box 3 
motif, regulates granulocytic differentiation and specific gene induction (Dong et al. 1993, 
Fukunaga et al. 1993, Ziegler et al. 1993). The precise role of individual tyrosine residues in 
terms of signaling activation and downstream cellular response has also been examined. 
Intriguingly, at least in vitro, and in contrast to the MCSFR, the GCSFR tyrosine residues 
appear to be dispensable for G-CSF signaling in saturated G-CSF concentration (Ward et al. 
1999).  
 The pivotal signaling mechanism of the GCSFR (and other receptors of its family) is 
through the JAK/STAT pathway. JAK/STAT signaling components activated through the 
GCSFR include JAK1, JAK2, TYK2, STAT1, STAT3, and STAT5 (Nicholson et al. 1994, 
Shimoda et al. 1997, Tian et al. 1994, 1996). The specific roles of JAK1, JAK2, and TYK2 in 
G-CSF signaling are still unclear. Using a JAK-deficient human fibrosarcoma cell line, it was 
suggested that JAK1, but not the other members, is critical for receptor phosphorylation and  
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Figure 3-5: Major GCSFR-activated signaling pathways. 
The GCSFR has three conserved domains known as Box 1-3 and four functional tyrosine residues. JAKs are 
constitutively associated with the GCSFR’s Box motives and are transphosphorylated and activated upon G-
CSF binding and homodimerization of the receptor. The JAKs then phosphorylate the intracelular GCSFR 
tyrosine residues, which in turn act as docking sites for STATs and other SH2-containing adaptor proteins. This 
results in activation of several signaling pathways that mediate G-CSF-induced effects. 
 
STAT activation (Shimoda et al. 1997). However, dominant negative forms of either JAK1, 
JAK2, or TYK2 coexpressed with wild type GCSFR in COS cels blocked STAT5 activation 
(Dong & Larner 2000). Additionaly, JAK1-deficient mice have a normal neutrophil count, 
speaking against a major non-redundant role for JAK1 (Rodig et al. 1998). STAT1 does not 
seem to be crucial: it is only weakly and transiently activated by G-CSF, and STAT1-
deficient mice do not show a defect in granulopoiesis (de Koning et al. 1998, Durbin et al. 
1996). STAT3, however, is robustly activated and docks on phosphorylated tyrosines Y704 
and Y744 of the human GCSFR (Chakraborty et al. 1999). Yet, conditional knockout mice 
with selective deletion of STAT3 in hematopoietic progenitors results in neutrophilia with a 
specific increase in late stage neutrophils, suggesting that STAT3 has a limiting function in 
late granulopoiesis, but is not required for the production of functional neutrophils in vivo 
(Lee et al. 2002). More recently, using mice with conditional deletion of STAT3 in BM, it 
was shown that STAT3 is required for stress-induced granulopoiesis by driving expression of 
C/EBPß (Zhang et al. 2010). STAT5 is activated independently of tyrosine residues, most 
likely through direct recruitment to JAKs (Dong et al. 1998, Fujitani et al. 1997). G-CSF-
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mediated activation of STAT5 is only transient and has been implicated in survival and 
proliferation (Dong et al. 1998). STAT5A and STAT5B double knockout mice show a 50% 
decrease in peripheral neutrophils, but this appears to be independent of G-CSF, indicating 
that STAT5 is required for granulocyte maintenance in vivo, but not for G-CSF-induced 
granulopoiesis (Kimura et al. 2009). 
Besides JAK/STAT, MAPK and PI3K/Akt signaling pathways are activated through 
G-CSF, and both were found to contribute to G-CSF-mediated survival and proliferation (de 
Koning et al. 1998, Dong & Larner 2000). Y764 of human GCSFR was found to have a 
major role in proliferation signaling in cell lines as well as in primary myeloid progenitors: 
Mutation of Y764 reduces proliferation of myeloid progenitors, while adding it back to a 
tyrosine null receptor background greatly increases proliferation (Akbarzadeh et al. 2002, de 
Koning et al. 1998, Hermans et al. 2003). Once phosphorylated, human Y764, as well as the 
murine equivalent Y763, was shown to bind Grb2 and SH2 domain containing protein (Shc), 
which are signaling intermediates of the MAPK pathway (De Koning et al. 1996, Rausch et 
al. 1997). Downstream of Y763/764, several MAPKs have been shown to be activated, 
including ERK, p38, and JNK (Bashey et al. 1994, Kendrick et al. 2004, Rausch & Marshall 
1999, Rausch et al. 1997). Activation of Akt signaling was found to be possible independent 
of JAKs and involves SFKs (Dong & Larner 2000, Zhu et al. 2006).  
The phosphatases SHP-1 and SHIP, and SOCS proteins seem to play a major role in 
the negative regulation of G-CSF signaling. SOCS1 and SOCS3 are both able to attenuate G-
CSF signaling by blocking JAK-induced STAT activation and possibly STAT ubiquitination 
(Geijn et al. 2004, Zhuang et al. 2005). G-CSF strongly induces transcription of SOCS3 via 
STAT3 as a negative feedback loop, while SOCS1 remains at a relatively low and constant 
level (Geijn et al. 2004). SOCS3 was shown to bind the activated human GCSFR on Y729 
(Hörtner et al. 2002). Conditional SOCS3 knockout mice, somewhat resembling the STAT3-/- 
phenotype, react hyperproliferative to G-CSF injection and cells show prolonged STAT3 
activation upon G-CSF stimulation in vitro (Croker et al. 2004). Besides blocking JAK/STAT 
signaling, SOCS proteins might also affect other pathways. Recently, SFKs Hck and Lyn, 
which have been shown to be activated by the GCSFR, were implicated in the negative 
regulation of G-CSF signaling and granulopoiesis (Mermel et al. 2006). 
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In summary, many signaling pathways have been described to be activated upon M- 
and G-CSF stimulation. However, if and/or to what extent the activated signaling cascades 
are involved in orchestrating the different cytokine-mediated cell fates is less clear and can 
vary between the cellular model systems used. Specifically, signaling pathways involved in 
transmitting lineage choice instruction remain elusive. Moreover, the identity of signaling 
pathways leading to lineage-specific transcription factor expression and/or activation is not 
well understood. Of note, signaling pathways activated by M-CSF and G-CSF are extensively 
overlapping, suggesting that other parameters (e.g. duration and strength of signaling) are 
also important. 
 
 
 
3.4 The need for single cell analysis in HSPC research 
 
 Clonal assays allowing the readout of all known differentiated blood cell types was a 
prerequisite for the discovery of hematopoietic stem cells by Till and McCulloch (Becker et 
al. 1963, Till & McCulloch 1961). Similarly, establishing cell culture assays that allowed the 
growth of colonies derived from single HSPCs led to the discovery of cytokines (Bradley & 
Metcalf 1966). Since then, single cell based assays have continued to contribute to the 
elucidation of many fundamentally important cellular and molecular aspects of HSPCs and 
their control. For example, single cell transplantations recently revealed the functional 
heterogeneity of the immunophenotypically homogenous HSC population (Dykstra et al. 
2007, Müller-Sieburg et al. 2002, Sieburg et al. 2006). This heterogeneity could not have 
been detected if not one, but several cells were transplanted, as in this case average output 
would have been read out. The same holds true for conventional biochemical approaches, 
which usually read out population averages and mask information on heterogeneity. Although 
flow cytometry gives single cell resolution and can unravel heterogeneous populations, it 
reflects only a snapshot in time and lacks information on changing cellular or molecular 
properties over time. Moreover, these classical methodologies either kill the cells of interest 
during sample preparation or lose the cells’ future identities. Therefore, relationships between 
current signaling state and future cell fate cannot be inferred by these methods. Fluorescent 
biosensors, which can visualize and quantify signaling activity in living cells, circumvent 
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these issues and in combination with continuous time-lapse imaging alow to link celular 
behavior and molecular dynamics to future cel fate (Figure 3-6) (Endele & Schroeder 2012). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-6: Continuous single cel analysis alows detection of celular genealogy and changing molecular 
properties obscured by population or snapshot analyses. 
(a) Only single cel analysis can detect how a single white cel gives rise to four red cels. Two possible 
scenarios are depicted that could not be distinguished by population and/or snapshot analyses. (b) Similarly, 
molecular behavior leading to upregulation (blue) or downregulation (red) of a given factor or signaling 
pathway cannot be detected by snapshot analysis of bulk cultures. Three possible scenarios are depicted. (c+d) 
Biosensors can detect signaling kinetics in real time within living cels and alow quantification of molecular 
behavior over time. (c) Translocation-based biosensors typicaly consist of a minimal protein binding domain 
fused to a fluorescent protein. External stimulation leads to the transient accumulation of a second messenger in 
a specific subcelular localization (e.g. a phospholipid in the plasma membrane), which is detected and bound by 
the sensor. This results in the translocation of the sensor to the membrane, thereby indicating signaling 
activation. (d) Fluorescence resonance energy transfer (FRET)-based biosensors contain a sensing domain, 
which is modified by the signaling activity of interest (e.g. through a kinase). Modification of the sensing 
domain leads to a conformational change of the sensor inducing FRET and thereby indicating signaling activity. 
Colored arrows indicate light of diferent wavelengths. Figure adapted from (Endele & Schroeder 2012, 
Schroeder 2011). GFP: green fluorescent protein; YFP: yelow fluorescent protein; CFP: cyan fluorescent 
protein. 
 
 Live cel imaging could recently provide evidence that M- and G-CSF can instruct the 
lineage choice of bipotent uncommited GMPs (Rieger et al. 2009). Similarly, live cel 
imaging can be used to dissect the pleiotropic actions M- and G-CSF exert on their target 
cels. Both cytokines afect many diferent cel fates that can be impossible to distinguish 
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when snapshots of bulk cultures are analyzed. In contrast, live cell imaging allows 
simultaneous detection and quantification of single cytokine-influenced parameters at the 
single cell level (Figure 3-3). For example, previous studies determined M-CSF-mediated 
proliferation effects by looking at population cell counts at several timepoints. However, in 
contrast to live cell imaging, these approaches cannot distinguish whether altered cell 
numbers resulted from changed cell death frequencies or from modulated cell cycle times, 
whose individual effect on total cell output cannot be determined by discontinuous, snap-shot 
analysis (Figure 3-6a). Moreover, live cell imaging allows quantification of the 
heterogeneous response of cells to cytokines (e.g. regarding the timepoint of commitment, 
differentiation, or morphological changes), generating valuable information that can be used 
to e.g. predict cell fates. 
___________________________________Aim of Thesis____________________________________ 
30 
 
4 Aim of Thesis 
 
Aim of this thesis was to elucidate signaling pathways involved in transmitting M-
CSF-instructed macrophage differentiation. To screen for candidate pathways, genetically 
modified MCSFRs lacking individual or several tyrosine residues ought to be analyzed in 
primary progenitor cells for their capability to transmit lineage-instructive signals. In order to 
simultaneously assess M-CSF-affected cellular parameters, continuous time-lapse imaging at 
the single cell level should be applied during these analyses. Complementing and confirming 
the MCSFR screening, small molecule inhibitors and loss and gain of function mutants of 
signaling molecules should be used to manipulate MCSFR downstream signaling. Finally, 
microarray analysis should be carried out to detect differences in M- and G-CSF-mediated 
gene expression during lineage commitment, potentially revealing differential mechanisms of 
lineage instruction between the two cytokines.    
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5 Material and Methods 
 
5.1 Molecular biology  
 
5.1.1 Plasmids 
 
Construct(s) Origin 
MCSFR mutants 
Akt constitutive active (CA) 
Akt dominant negative (DN) 
Fyn CA, Lyn CA, c-Src CA 
Hck CA 
Src DN 
p65 
STAT3 CA, DN 
pRRL.PPT.SFFV.IRES.VENUSnucmem.PRE 
(lentiviral backbone) 
(Yu et al. 2008, 2012) 
(Orsulic et al. 2002) 
(Zhou et al. 2000) 
(Cai et al. 2011) 
(Scholz et al. 2000) 
Plasmid 13657 (www.addgene.org) 
(Lee et al. 2009) 
(Bromberg et al. 1999) 
(Schambach et al. 2006) 
 
 
5.1.2 Cloning strategies 
  
 Cloning strategies were pre-designed in silico using Clone Manager Professional 9 
software (Scientific & Educational Software, Cary, USA) based on complete sequences of 
available plasmids.  
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5.1.3 Restriction digests and ligations  
  
 Restriction digests, ligations, generation of blunt-ended DNA fragments, and DNA 
dephosphorylation were conducted using enzymes and suitable buffers from either New 
England Biolabs (Ipswich, USA) or Thermo Fisher Scientific (Waltham, USA) according to 
manufacturer’s instruction.  
 
 
5.1.4 Polymerase Chain Reaction (PCR) 
 
 PCR primers and strategy including annealing and melting temperatures were 
designed with Clone Manager Professional 9 software. PCR was conducted according to 
manufacturer’s instruction using either Taq polymerase from Thermo Fisher Scientific (Cat. 
Nr. EP0072, Waltham, USA) for animal genotypings or Advantage Polymerase 2 from 
Clontech (Cat. Nr. 639206, Mountain View, USA) for cloning purposes.  
 
 
5.1.5 Agarose gel electrophoresis  
 
 DNA fragments from restriction digests and PCR products were separated on 0.7% to 
1.5% agarose (Cat. Nr. 840004, Biozym, Oldendorf, Germany) gels prepared with 1xTAE-
buffer composed of 40mM tris-(hydroxymetyhl)-aminomethane (TRIS) (Cat. Nr. 5429.3, 
Roth, Karlsruhe, Germany), 20mM acetic acid (Cat. Nr. 1000632511, Merck, Darmstadt, 
Germany) and 1mM ethylenediaminetetraacetate (EDTA) (Cat. Nr. 8043.2, Roth, Karlsruhe, 
Germany). Agarose gels were stained with 1% ethidium bromide solution (Cat. Nr. 2218.2, 
Roth, Karlsruhe, Germany) at a concentration of 6µl per 100ml agarose solution. DNA 
fragments were separated with voltages between 80V and 150V in 1xTAE-buffer. 
 
 
5.1.6 Purification of DNA fragments 
 
 DNA fragments were excised from agarose gels and purified using the QIAquick Gel 
Extraction Kit (Cat. Nr. 28704, Qiagen, Hilden, Germany) according to manufacturer’s 
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instruction. Purification of PCR products was carried out using the QIAquick kit (Cat. Nr. 
28104, Qiagen, Hilden, Germany) according to manufacturer’s instruction. DNA fragments 
were resuspended in H2O bidest and DNA concentration was measured using a NanoDrop 
spectrophotometer nd-1000 (Thermo Scientific, Waltham, USA). 
 
 
5.1.7 Transformation of bacteria 
 
 Chemical competent DH5α Escherichia coli bacteria were thawed on ice. 1-100ng of 
plasmid or ligation cocktail was added to the bacteria suspension followed by incubation on 
ice for 30min. After heatshock treatment of bacteria for 90s at 42°C and cooling on ice for 
2min, bacteria were incubated in LB-medium at 37°C for 1h. Different dilutions of the 
bacteria suspension were plated on LB agar (Cat. Nr. 244520, Becton Dickinson, Franklin 
Lakes, USA) plates containing adequate antibiotics for selection of successfully transformed 
bacteria. LB agar plates were incubated overnight at 37°C.  
 
 
5.1.8 Isolation of plasmid DNA 
 
 High copy plasmids from DH5α Escherichia coli bacteria were purified from 4ml 
overnight cultures using the QIAprep Spin Miniprep Kit (Cat. Nr. 27104, Qiagen, Hilden, 
Germany) according to manufacturer’s instruction or a modified protocol replacing columns 
with an isopropanol (Cat. Nr. 6752.2, Roth, Karlsruhe, Germany) precipitation step. 
Purification from 200ml overnight cultures was performed using Qiagen Plasmid Maxi Kit 
(Cat. Nr. 12165, Qiagen, Hilden, Germany) according to manufacturer’s instruction.  
 
 
5.1.9 DNA ethanol precipitation 
 
 DNA solutions were mixed with 3M sodium acetate (10% of sample volume) (Cat. 
Nr. 6773.1, Roth, Karlsruhe, Germany), followed by addition of 100% ethanol (2x sample 
volume). Solutions were incubated at -20°C overnight and then centrifuged in a table-top 
centrifuge at maximum speed for 15minutes at 4°C. Supernatants were removed and DNA 
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pellets washed with ice-cold 70% ethanol. After another centrifugation step and removal of 
supernatants, pellets were air-dried and resolved in H2O. 
 
 
5.1.10 DNA sequencing 
 
 PCR reactions for sequencing were performed using the BigDye Terminator v3.1 
Cycle Sequencing Kit (Cat. Nr. 4337455, Applied Biosystem, Foster City, USA) according to 
manufacturer’s instruction. After DNA ethanol precipitation, capillary sequencing was 
performed in the in-house sequencing facility on a 3730 DNA Analyzer (Applied Biosystem, 
Foster City, USA). 
 
 
 
5.2 Generation of lentivirus  
 
5.2.1 Virus production 
 
 Vesicular stomatitis virus glycoprotein (VSV-G) pseudotyped lentivirus was produced 
in human embryonic kidney (HEK) 293T cells. HEK cells were cultured in Dulbecco's 
modified Eagle medium (DMEM) (Cat. Nr. 41966-029, Invitrogen, Karlsruhe, Germany) 
with 10% fetal calf serum (FCS) (Cat. Nr. S1900-500, Lot Nr. S05130S1900, Biowest SAS, 
Nuaillé, France). For each virus four 10cm dishes (Cat. Nr. 150350, Thermo Scientific, 
Waltham, USA) were seeded with 5x106 HEK cells each. The next day plates were 
cotransfected with viral packing plasmids (2.5µg pRSV_rev, 5µg pMDLg_pRRE, and 1µg 
pMD2.VSV-g) and 10µg the plasmid containing the gene of interest (derived from 
pRRL.PPT.SFFV.GFP.PRE (Figure 5-1) (Schambach et al. 2006)) in 0.5ml 250mM calcium 
chloride (CaCl2) HEPES-buffered saline (HBS) (Cat. Nr. CAPHOS, Sigma-Aldrich, 
Taufkirchen, Germany). Prior to transfection, the medium was replaced with DMEM, 10% 
FCS, 0.1mM non-essential amino-acids (Cat. Nr. 11140-035, Invitrogen, Karlsruhe, 
Germany), 1mM sodium pyruvate (Cat. Nr. S8636, Sigma-Aldrich, Taufkirchen, Germany), 
20mM HEPES (Cat. Nr. 15630-056, Invitrogen, Karlsruhe, Germany), and 100U/ml and 
100µg/ml penicillin/streptomycin (Cat. Nr. 15140122, Invitrogen, Karlsruhe, Germany). Two 
________________________________Material and Methods________________________________ 
35 
 
days after transfection, the virus-containing medium from 4 dishes was colected, centrifuged 
at 400g at 4°C for 5min, and the supernatant filtered through a 0.2µm filter (Cat. Nr. 17805, 
Sartorius, Götingen, Germany). Supernatant was then centrifuged at 50000g at 4°C for at 
least 1h. The supernatant was aspirated and pelets were resuspended in 200µl StemSpan 
serum free expansion medium (SFEM) (Cat. Nr. 09650, Stem Cel Technologies, Vancouver 
Canada), aliquoted in 10µl vials, and frozen at – 80 °C until further use. 
 
 
Figure 5-1: Basic map of lentiviral backbone used. 
The expression of the inserted gene of interest is driven by the spleen focus forming virus (SFFV) promoter. The 
fluorescent protein Venus serves as a reporter and can be used to FACS purify positively transduced cels. LTR: 
long terminal repeat; IRES: internal ribosomal entry site. 
 
 
5.2.2 Virus titration 
 
  Viral titers were determined by infecting NIH-3T3 cels and quantifying transduced 
cels by flow cytometry via a fluorescent transduction marker. NIH-3T3 cels were cultured 
in DMEM/10% FCS and seeded at a density of 1.5x104 cels per wel of a 24-wel plate (Cat. 
Nr. 131068, Thermo Scientific, Waltham, USA). The next day a 1:10 dilution series of 
lentivirus was prepared and cels were infected with each dilution in triplicates. Two days 
later, medium was removed, cels were trypsinized (Cat. Nr. 25300-054, Invitrogen, 
Karlsruhe, Germany), counted, and analyzed on a FACSCalibur or FACSAriaII (Beckton 
Dickinson, San Jose, USA). The percentage of fluorescent marker positive cels was used for 
titer calculation. 
 
 
5.2.3 Virus infection of preGMPs 
 
  Cels were sorted, counted, and cultured overnight in 100µl SFEM containing 
100ng/ml stem cel factor (SCF) (Cat. Nr. 250-03), 100ng/ml Flt3L (Cat. Nr. 250-31L, both 
PeproTech, Hamburg, Germany) in a wel of a 96-wel plate. Lentivirus was then added at a 
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multiplicity of infection (MOI) of 50 – 100. Cells were incubated at 37°C for 48h before 
further usage.  
 
 
 
5.3 Isolation and transplantation of primary murine cells 
 
5.3.1 Mouse lines  
 
 All mice were housed in a specific pathogen free (SPF) environment and sacrificed by 
CO2 asphyxiation. All mice used for experiments were 12-16 weeks old and included 
C57BL/6J wild type mice from the in-house breeding facility, LysM:EGFP mice (Faust et al. 
2000), MCSFR-/- mice (Dai et al. 2002), c-kitW41/W41 mice (Geissler et al. 1981), bcl2-
overexpressing mice (Ogilvy et al. 1999), and intercrosses of those.  
 
 
5.3.2 Isolation and transplantation of fetal liver cells 
 
 Fetal livers from MCSFR-/- E14.5 day embryos were isolated, pooled, and 
singularized by vigorous pipetting in PBS. Adult W41 mice were tail vein-injected with 
2x107 fetal liver cells resuspended in 200-400µl of PBS using insulin syringes (Cat. Nr. 
9151133, B.Braun, Melsungen, Germany). Contribution of donor cells was analyzed in 
recipients’ peripheral blood (collected from the tail vein) using flow cytometry.   
 
 
5.3.3 Isolation of bone marrow cells 
 
 For analysis and sorting of mononuclear cells from murine bone marrow, femurs, 
tibiae, humeri, hip bones, and vertebrae from adult mice were isolated. Bones were crushed 
using mortar and pestle in cold PBS/2% FCS and filtered through a 40µm filter (Cat. Nr. 
352340, Becton Dickinson, Franklin Lakes, USA) in a total volume of 50ml. The cell 
suspension was centrifuged at 400g at 4°C for 5min. The pellet was then resuspended in 
ACK erythrocyte lysis buffer (500µl/mouse) (Cat. Nr. 10-548E, Lonza, Basel, Switzerland) 
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and incubated at 4°C for 2min. After washing with PBS, cells were counted using a 
hemocytometer.  
 Alternatively, femurs and tibiae of adult mice were isolated, flushed with 6ml cold 
PBS and isolated from the interphase of a Histopaque-1083 Ficoll gradient (Cat. Nr., 10831, 
Sigma-Aldrich, Taufkirchen, Germany) after centrifugation for 15min at room temperature at 
490g with minimal acceleration and no brake. 
 
  
5.3.4 Staining of primary cells for flow cytometry 
 
 Freshly isolated cells were resuspended in FACS buffer (PBS, 10% FCS, 0.1% 
sodium azide (NaN3) (Cat. Nr. S2002, Sigma-Aldrich, Taufkirchen, Germany), and 10mM 
EDTA) to a concentration of 108 cells per ml. For analysis and sorting of BM-HSPCs, 1µl per 
biotinylated lineage-antibody was added per 107 cells followed by incubation on ice for 
20min. Lineage-antibodies included CD3 (clone: 17A2, Cat. Nr. 13-0031), CD19 (clone: 
eBio1D3 (1D3), Cat. Nr. 13-0193), B220 (clone: RA3-6B2, Cat. Nr. 13-0452), Gr1 (Cat. Nr. 
13-5931), MacI (clone: M1/70, Cat. Nr. 13-0112), Ter119 (clone: TER-119, Cat. Nr. 13-
5921) and CD41 (clone: eBioMWReg30 (MWReg30), Cat. Nr. 13-0411, all eBioscience, San 
Diego, USA). If cells were prepared for sorting, a magnetic depletion of lineage positive cells 
was performed: Cells were washed, centrifuged, and resuspended in FACS buffer to a 
concentration of 108 cells per ml. Streptavidin-coated magnetic beads (Cat. Nr. HP57.1, Roth, 
Karlsruhe, Germany) were added to the cells (2µl per 107 cells) and incubated on ice for 
10min. Cells were then incubated on an EasySep magnet (Cat. Nr. 18001, Stem Cell 
Technologies, Vancouver, Canada) for 10min and lineage-negative cells were decanted. Cells 
were washed, counted, centrifuged, and resuspended in FACS buffer (100µl per mouse). 
Antibodies and streptavidin labeled with fluorescent dyes were added to the cells (2-3µl/107 
cells) and incubated on ice for at least 30min. If the cells to be stained were already in 
culture, no lineage depletion was performed. If CD16/32 was stained, the antibody was added 
to the cells first to block unspecific binding of Fc fragments. Antibodies used for staining 
were CD105-PE (clone: MJ7/18, Cat. Nr. 12-1051-82), CD34-eFluor660 (clone: RAM34, 
Cat. Nr. 50-0341-82), c-kit-PE-Cy7 (clone: 2B8, Cat. Nr. 25-1171-82), Ter119-APC-
eFluor780 (clone: TER-119, Cat. Nr. 47-5921-82), MacI-eFluor450 (clone: M1/70, Cat. Nr. 
48-0112-82), F4/80-eFluor450 (clone: BM8, Cat. Nr. 48-4801-82, all eBiocience, San Diego, 
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USA), CD16/32-APC (clone: 93, Cat. Nr. 101326), CD150-PE (clone TC15-12F12.2, Cat. 
Nr. 115904), Sca-1-PB (clone: D7, Cat. Nr. 108120), Ly6G (clone: 1A8, Cat. Nr. 127608, all 
Biolegend, San Diego, USA), CD16/32-FITC (clone: 2.4G2, Cat. Nr. 553144), and CD16/32-
PE (clone: 2.4G2, Cat. Nr. 553145, all Becton Dickinson, Franklin Lakes, USA). APC-
eFluor780-labeled streptavidin (Cat. Nr. 47-4317-82, eBioscience, San Diego, USA) was 
used to stain biotin-labeled lineage markers. 
 After staining, cells were washed, centrifuged, resuspended in FACS Buffer (200-400 
µl per mouse), and filtered through a 35µm filter (Cat. Nr. 352235, Becton Dickinson, 
Franklin Lakes, USA) into polypropylene round-bottom tubes (Cat. Nr. 352063, Becton 
Dickinson, Franklin Lakes, USA).  
 
 
5.3.5 Flow cytometry and cell sorting 
 
 Flow cytometry and sorting was performed on a FACSAriaIII (Becton Dickinson, 
Franklin Lakes, USA) equipped with 405nm, 488nm, 561nm, and 633nm lasers using a 70µm 
nozzle and manually adjusted compensations required for multi-color staining. Cells were 
sorted in ‘purity’ or ‘4-way-sort’ mode into 4°C cold SFEM. A sorting purity of ≥95% was 
confirmed by reanalysis of sorted populations. Flow cytometry data was analyzed using 
FACSDiva software version 6.1.3 (Becton Dickinson, Franklin Lakes, USA). 
 
 
 
5.4 Cell culture of primary HSCPs 
 
5.4.1 Liquid culture 
 
 FACS-purified HSPCs were cultured in SFEM containing either a permissive 
cytokine cocktail (100ng/ml SCF, 10ng/ml IL-3 (Cat. Nr. 213-13), 100ng/ml TPO (Cat. Nr. 
315-14, all PeproTech, Hamburg, Germany), 2U/ml EPO (Cat. Nr. C-60023, Promokine, 
Heidelberg, Germany), 10%FCS) or instructive cytokines (20ng/ml M-CSF (Cat. Nr. 315-02) 
± 20ng/ml G-CSF (Cat. Nr. 250-05, all PeproTech, Hamburg, Germany) ± 10%FCS). For 
inhibitor experiments, cells were starved in presence of inhibitors for 1h before adding 
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cytokines. Inhibitors used were Ly294002 (Cat. Nr. 440204, Merck, Darmstadt, Germany), 
SU6656 (Cat. Nr. 572636-500UG Merck Millipore, Darmstadt, Germany), PD0325901 (Cat. 
Nr. 04-0006, Stemgent, Cambridge, USA), SB203580 (Cat. Nr. 5633S, Cell Signaling 
Technology, Beverly, USA), and Nemo binding domain (NBD) inhibitory peptide (Cat. Nr. 
IMG-2000, Biomol, Hamburg, Germany).   
 
 
5.4.2 Colony assay 
 
 FACS-purified cells were counted and seeded at suitable densities in 35mm dishes 
(Cat. Nr. 430165, Corning, Amsterdam, Netherlands) with MethoCult GF M3434 colony 
assay medium (Stem Cell Technologies, Vancouver, Canada) containing cytokines SCF, IL3, 
IL6, and EPO according to manufacturer’s instruction. After 5-7 days, colonies with at least 
30 cells were scored according to morphology of cells and colonies and live in-culture 
antibody staining. 
 
 
5.4.3 Live in-culture antibody staining 
 
 Live antibody staining in liquid cultures or colony assays was performed as described 
(Eilken et al. 2011). Either commercially available (MacI-PE) or self-labeled antibodies were 
used (F4/80-AlexaFluor647). Antibodies were labeled using the AlexaFluor 647 Labeling Kit 
(Cat. Nr.  A-20186, Invitrogen, Karlsruhe, Germany) according to manufacturer’s protocol. 
Antibodies were added to cell cultures at a final concentration of 10 - 50ng/ml.  
 
 
 
5.5 Cytospin  
 
5.5.1 Cytospin 
  
 Up to 1ml of cell suspension was transferred to object slides captured with Hettich 
cytospin equipment (Cat. Nr 1662, 1668, 5280, Hettich, Tuttlingen, Germany). Slides were 
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centrifuged at 270g (Rotanta 460 R centrifuge (Cat. Nr. 5660, Hettich, Tuttlingen, Germany)) 
and room temperature for 3min. Supernatants were aspirated, the cyto-chamber removed, and 
slides centrifuged at 1100g for 1min.  
 
 
5.5.2 Cytospin staining and analysis  
 
 Cytoplasm and granulae of cytospun cells were stained with May-Gruenwald-
Solution (Cat. Nr. T863.1, Roth, Karlsruhe, Germany) for 4min. Cells were washed twice 
with H2O bidest, and subsequently nuclei were stained with a 5% Giemsa-Solution (Cat. Nr. 
1.09204.0500, Merck, Darmstadt, Germany) for 16min. Cells were washed 3 times with H2O 
bidest, air-dried, and covered with Pertex mounting medium (Cat. Nr. PER20000, Medite, 
Burgdorf, Germany). Cytospins were analyzed using a 63x oil-immersion objective on an 
Axiovert 200M inverted microscope. 
 
 
 
5.6 Immunofluorescence  
 
 For immunofluorescent staining, cells were seeded on poly-lysine (Cat. Nr. P8920, 
Sigma-Aldrich, Taufkirchen, Germany)-coated slides, fixed with 2% paraformaldehyde (Cat. 
Nr. 158127, Sigma-Aldrich, Taufkirchen, Germany) in PBS at room temperature for 10min 
and subsequently permeabilized by 0.2% Triton-X (Cat. Nr. T8787, Sigma-Aldrich, 
Taufkirchen, Germany) in PBS. Next, cells were incubated with blocking buffer (PBS/10% 
donkey serum (Dianova, Hamburg, Germany)) at room temperature for 1h. Incubation with 
primary antibodies was performed overnight in blocking buffer. After washing, cells were 
incubated with secondary antibody at room temperature for 1h. Slides were mounted with 
Vectashield containing DAPI (Cat. Nr. H-1200, Vector laboratories, Burlingame, USA) and 
analyzed using a confocal microscope (TCS SP5, Leica, Wetzlar, Germany). Cells were 
stained with an anti-phospho-Src antibody (1:100) (clone: 9A6, Cat. Nr. 05-677, Merck 
Millipore, Darmstadt, Germany) detected with a donkey-anti-mouse AlexaFluor555-
conjugated secondary antibody (Cat. Nr. A-31570, Life Technologies, Carlsbad, USA). 
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5.7 Time-lapse imaging 
 
5.7.1 Movie acquisition 
 
 Time-lapse movies were acquired on an inverted epifluorescence microscope (Axio 
Observer, Zeiss, Hallbergmoos, Germany) using AxioVision Software 4.9. A self-written 
macro (TAT) was used to control hardware equipment in AxioVision. Microscopes were 
enclosed in plexiglass housings, allowing cells to be constantly kept at 37°C through a 
Heating Unit XL S (Cat. Nr. 411857-9030-000, Zeiss, Hallbergmoos, Germany). Cells were 
directly supplied with pre-mixed gas consisting of 5% CO2, 5% O2 and 90% N2 (Praxair, 
Düsseldorf, Germany). Images were acquired with a 10x Fluar objective (Cat. Nr. 440135-
0000-000, Zeiss, Hallbergmoos, Germany) and a 0.5-1x TV-Adapter (Cat. Nr., 426113-0000-
000 Zeiss, Hallbergmoos, Germany). The brightfield lightsource was a halogen lamp and 
images were acquired every 2-3min with an Axiocam HRm (Cat. Nr. 426511-9901-000, 
Zeiss, Hallbergmoos, Germany) camera at a resolution of 1388 x 1040 pixels in lossless TIF 
or PNG format. Fluorescent light was provided either by a HXP 120 light source (Cat. Nr. 
423013-9010-000, Zeiss, Hallbergmoos, Germany) with an Osram HXP-R 120W/45C VIS 
bulb (Cat. Nr. 882772, Osram, Munich, Germany) or a SPECTRA X light engine 
(Lumencore, Beaverton, USA). Filters for excitation/emission of different fluorophores were 
46 HE (Cat. Nr. 489046-9901-000, Zeiss, Hallbergmoos, Germany) for VENUS, 43 HE (Cat. 
Nr. 489043-9901-000, Zeiss, Hallbergmoos, Germany) for PE, and AHF Cy5 (Cat. Nr. F46-
006, AHF Analysentechnik, Tübingen, Germany) for AlexaFluor 647. Excitation times were 
between 20 and 500ms. Hardware autofocus (Cat. Nr. 410133-0506-000, Zeiss, 
Hallbergmoos, Germany) was applied on brightfield images every 1-2h. Fluorescent images 
were acquired every 2-3h. 
 
 
5.7.2 Tracking software 
 
 Time-lapse data was retrospectively analyzed using self-written tracking software 
TTT on Fujitsu Siemens (Munich, Germany) workstations. The software allows manual 
tracking of individual colonies at the single-cell level generating cell genealogies with exact 
information about several parameters, including division frequencies, cell cycle length, cell 
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death frequencies, or cell movement. Furthermore, onsets of marker expression as detected 
via live antibody staining as well as appearance of morphological features (e.g. adherence) 
can be manually annotated. Any cell with insecure identity (loss of single cell data) was 
excluded from analysis. For statistical analysis of TTT data, self-written software StaTTTs 
was used. StaTTTs allows the generation of tree and cell filters to quantify parameters 
annotated in TTT. 
 
 
5.8 Gene expression analysis 
 
5.8.1 Reverse transcriptase real-time PCR 
 
 Cells in culture were washed once with PBS and then lysed. Total RNA extraction 
and cDNA synthesis was performed using the RNeasy Plus Micro kit (Cat. Nr. 74034, 
Qiagen, Hilden, Germany) including digestion of remaining genomic DNA and the 
SuperScript III kit (Cat. Nr. 18080-051, Invitrogen, Karlsruhe, Germany), respectively, 
according to manufacturer’s instruction. The PCR reaction was carried out using SYBR 
Green Master Mix (Cat. Nr. 4367659) on a QuantStudio 12k Flex system (both Applied 
Biosystems, Foster City, USA). Primers used were:  
 
Gene:  Forward primer:   Reverse primer: 
Hck  5-GTCCAGGTTCCTCCGAGATG-3  5-CCATCTGGTCTCCCTTCTGG-3 
Fgr  5-ATTCGTCGCCCTGTACGACT-3  5-CTTTGGTGGTCTCGCTTTCC-3 
Lyn  5-GCAAAGGCCAGTTCCTGAAT-3  5-CAGAAGCTGTCGCTCTGCAT-3 
Src  5-CAGCAACAAGAGCAAGCCCA-3  5-TATTGACAATCTGCAGCCGC-3 
Yes  5-TGGAGGAGCGTCTTCCTCAT-3  5-CATTGTCACCCCTCACCTCA-3 
Fyn  5-GAGAGCGAAACCACCAAAGG-3 5-AGCCACACTTCAGCGAAACA-3 
Yrk  5-CTCAAGCCCGAGAACATCCT-3  5-CAGATGTCGATGGCCAGGT-3 
Lck  5-CCAGAACCAGGGAGAAGTGG-3 5-TGCAGCTGCTTCATGAGGTT-3 
Blk  5-GGTCAGTGAGAAGGGCAAGG-3 5-CACAAAGTTGCTGGGCACAT-3 
ß-actin  5-CGTGGGCCGCCCTAGGCACCA-3 5-TTGGCCTTAGGGTTCAGGGGGG-3  
________________________________Material and Methods________________________________ 
43 
 
5.8.2 Microarray analysis 
 
 Microarray analyses were performed by Dr. Martin Irmler (Institute of Experimental 
Genetics, Helmholtz Center Munich) and analyzed with the help from Dr. Stavroula Skylaki 
(Research Unit Stem Cell Dynamics, Helmholtz Center Munich). 
 Total RNA was isolated employing the RNeasy Plus Micro kit (Cat. Nr. 74034, 
Qiagen, Hilden, Germany) including digestion of remaining genomic DNA. The 2100 
Bioanalyzer (Agilent Technologies, Oberhaching, Germany) was used to assess RNA quality 
and only high quality RNA (RIN>7) was used for microarray analysis. 
 Total RNA (about 2ng) was amplified using the Ovation PicoSL WTA System V2 
(Cat. Nr.: 3302) in combination with the Encore BiotinIL Module (both NuGEN, San Carlos, 
USA). 750ng of amplified cDNA was hybridized to Mouse Ref-8 v2.0 Expression BeadChips 
(Cat. Nr.: BD-202-0202, Illumina, San Diego, USA). Staining and scanning were done 
according to the Illumina expression protocol. Data was processed using the GenomeStudio 
V2010.1 software (gene expression module version 1.6.0) (Illumina, San Diego, USA) in 
combination with the MouseRef-8_V2_0_R3_11278551_A.bgx annotation file. The numbers 
of microarrays utilized for data analysis were as follows: no cytokine (2), M-CSF 2h (3), M-
CSF 24h GFP_lo (3), M-CSF 24h GFP_hi (3), M-CSF 48h GFP (3), G-CSF 2h (3), G-CSF 
24h GFP_lo (4), G-CSF 24h GFP_hi (3), G-CSF 48h GFP (2).  
Microarray data analysis was performed in the R statistical environment using the 
lumi package (Du et al. 2008). Data pre-processing was performed using background 
subtraction, variance stabilizing transformation (VST) and robust spline normalization 
(RSN). Differentially expressed genes were identified using the limma package with fold-
change (FC) ≥ 1.5 and FDR ≤ 0.05 (Smyth 2005). Differentially expressed genes (DEGs) in 
any two subpopulation comparison (2906 DEGs in total) were used for further analysis. 
Hierarchical clustering and K-means clustering was performed using Cluster 3.0 (de Hoon et 
al. 2004) and Java Treeview (Saldanha 2004) was used for visualization. 
Gene lists were subjected to standard gene ontology (GO) term enrichment analysis 
through Database for Annotation, Visualization and Integrated Discovery (DAVID) 
(http://david.abcc.ncifcrf.gov) (Huang et al. 2009). For pathway finding, gene lists were 
analyzed with Genomatix Pathway System (GePS) (http://www.genomatix.de). To visualize 
gene expression changes over time, data was loaded into Grid Analysis of Time series 
Expression (GATE) software (MacArthur et al. 2010). 
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5.9 Statistical analysis  
 
All statistical analyses were determined with Prism software (GraphPad Software Inc., 
La Jolla, USA). When data were assumed to meet normal distribution, an unpaired two-sided 
Student’s t-tests was performed to determine the significance of the difference between 
means of two groups. When data was not normally distributed, a non-parametric Mann-
Whitney U test was performed to detect significant differences in the distributions of two 
unmatched groups. The variance was similar between groups that were statistically 
compared. All data are plotted as mean±standard error of the mean (SEM) unless differently 
stated. The SEM indicates the precision of an estimated mean. The number (n) of biological 
repeats (samples obtained from experiments repeated on different days and starting from 
different mice) and single colonies/cells (in case of time-lapse movies) included in the final 
statistical analysis is indicated in each figure legend. 
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6 Results 
 
6.1 Establishment of a system to study the role of individual MCSFR tyrosine residues 
in primary MCSFR-deficient GMPs 
 
 Numerous studies over the last decades have attempted to elucidate the functional role 
of individual MCSFR tyrosine residues using a variety of cellular systems and experimental 
approaches. Many of these studies have led to contradictory results regarding the function of 
single tyrosine residues and concomitant consequences on downstream cellular fates 
(Hamilton 1997a,b). These discrepancies most likely arose from the different, often artificial, 
model systems used and exemplify the importance to study MCSFR function in the correct 
cellular context. Therefore, we set out to establish a system allowing the study of single 
MCSFR tyrosine function in primary cells physiologically responding to M-CSF. GMPs are a 
bipotent, BM-resident progenitor population that during hematopoiesis gives rise to 
granulocytes and macrophages (Akashi et al. 2000), which is physiologically controlled by 
the cytokines G-CSF and M-CSF, respectively. Therefore, GMPs represent the appropriate 
cellular model system to study MCSFR structure/function. As GMPs endogenously express 
the MCSFR, we sought out to use MCSFR-deficient mice to set up the experimental system. 
However, the described MCSFR knock-out mouse model is neonatal lethal when bred onto 
the C57BL/6 mouse genetic background, which is the preferred background in hematologic 
research (Dai et al. 2002, Li et al. 2006). In order to obtain adult BM-derived MCSFR-/- cells 
of C57BL/6 background, we took advantage of White Spotting mice (Geissler et al. 1981). 
These lines of mice bear different spontaneous point mutations in the gene encoding for c-kit 
(the receptor for the cytokine SCF), resulting in partial loss of c-kit function and concomitant 
defects in sustained HSC self-renewal (Miller et al. 1997). Due to these defects, c-kit mutant 
mice accept syngenic wild type HSCs, allowing long term engraftment and amplification of 
donor cells without prior irradiation (Capel & Mintz 1989, Migliaccio et al. 1999). In this 
study we used c-kitW41/W41 (W41) mice, bearing a c-kit mutation of milder phenotype, which 
in contrast to more severe mutations allows homozygous breeding.  
To test W41 mice as a potential recipient for MCSFR-/- cells, we transplanted W41 
mice intravenously with 2x107 unfractionated E14.5 fetal liver cells (corresponding to one 
fetal liver) of MCSFR-/- or wild type (littermate control) genotype. Engraftment was 
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measured bi-weekly in peripheral blood by flow cytometry. Donor cels (CD45.2) can be 
distinguished from recipient cels (CD45.1) by detecting the alelic variants CD45.1/CD45.2 
in flow cytometry using variant-specific antibodies (Figure 6-1a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-1: Transplantation strategy to obtain BM-derived MCSFR-/- progenitors. 
(a) Experimental scheme. W41 (CD45.1) mice were transplanted intravenously with 2x107 E14.5 fetal liver cels 
of wild type or MCSFR-/- (CD45.2) genotype. Donor contribution was checked at various timepoints in 
recipients’ peripheral blood or bone marrow via flow cytometry. (b) Donor contribution to peripheral blood 
shows no difference between wild type and MCSFR-/- donor cels, regarding both degree and kinetics (n=3-6 per 
timepoint per genotype). Data points represent mean±SEM. (c) Donor contribution to bone marrow myeloid 
progenitors 8 weeks post transplantation shows no diference in the degree of contribution between wild type 
and MCSFR-/- cels (n=3 per genotype). (d+e) Freshly isolated GMPs from C57Bl/6 (wt), W41 transplanted with 
wild type fetal liver cels (wt (transpl.)), or W41 transplanted with MCSFR-/- fetal liver cels (MCSF-/-) were 
cultured in colony assay medium containing either (d) SCF, IL3, IL6, and EPO (M3434) or (e) M-CSF. After 5-
7 days, colonies were enumerated and identified according to morphology (n=3 per genotype per condition). 
Bars represent mean±SEM. An unpaired Student’s t-test was used to determine the significance of the diference 
between means of two groups. *<0.05, **<0.01, ***<0.001 compared to wt. 
 
  Peripheral blood contribution increased steadily over time irrespective of donor 
genotype. Eight weeks post transplantation, donor contribution reached 57.1±2.6% for wild 
type and 55.8±4% (mean±SEM) for MCSFR-/- (Figure 6-1b). Furthermore, there was no 
diference in the kinetic of contribution when comparing wild type and MCSFR-/- donor fetal 
liver cels, demonstrating that the lack of the MCSFR is not detrimental for the engraftment 
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and differentiation of HSPCs. Recipients were sacrificed after eight weeks to check donor 
contribution in the BM. Similar to donor contribution in peripheral blood, no difference was 
detected when comparing wild type (85.5±1.9%) with MCSFR-/- (84.7±3.4%, mean±SEM) 
donor contribution to myeloid progenitors in the BM (Figure 6-1c). Contribution to BM 
populations at timepoints later than eight weeks only increased marginally (data not shown). 
MCSFR-/- GMPs purified from W41 mice had the same lineage potential as wild type GMPs 
derived from either C57BL/6 mice or from W41 transplanted with wild type fetal liver cells, 
as assessed by permissive (i.e. all lineages a given cell can potentially differentiate to are 
supported) colony assays (M3434-medium, containing SCF, IL3, IL6, and EPO) (Figure 6-
1d). This demonstrates that the transplantation per se has no influence on the generation of 
GMPs. As expected, MCSFR-/- GMPs purified from W41 were unable to form colonies in M-
CSF colony assays (Figure 6-1e).  
 In summary, transplantation of W41 mice with MCSFR-/- fetal liver cells proved to be 
a suitable approach to obtain BM-derived MCSFR-/- progenitors of C57BL/6 genetic 
background. 
 GMPs are a transient BM population and quickly differentiate into monopotential 
cells. This makes it difficult to genetically manipulate GMPs before differentiation to study 
the biological effects of ectopically expressed genes. We therefore set out to establish an in 
vitro differentiation system that would give rise to GMPs and at the same time allow time for 
transgene expression. To this end, preGMPs, an immediate precursor population of GMPs 
(Pronk et al. 2007), were FACS purified and cultured in SCF and Flt3L (Figure 6-2a, b) to 
allow time for genetic manipulation during the generation of GMPs in vitro. As a control, 
GMPs were cultured in the same cytokine conditions. When reanalyzing the cells after three 
days in culture, preGMPs (originally sorted as CD16/32lo MacIneg) gave rise to a CD16/32hi 
MacIneg population, which is immunophenotypically identical to BM-derived GMPs (Figure 
6-2b). In contrast, cultured GMPs retained high CD16/32 expression, and virtually all cells 
expressed MacI (CD11b), an early marker for myeloid differentiation. Repeating the 
experiments with LysM:EGFP mice (Faust et al. 2000) revealed that 30% of preGMP-derived 
CD16/32hi MacIpos cells expressed the lineage commitment marker lysozyme M (Rieger et al. 
2009), while none of the CD16/32hi MacIneg cells did (Figure 6-2b). CD16/32hi MacIneg cells 
therefore represent uncommitted progenitors. Consequently, we decided to exclude MacIpos 
cells in order to minimize the risk of having already pre-committed cells in the sorted 
______________________________________Results______________________________________ 
48 
 
population. The CD16/32hi MacIneg population was termed “in-vitro derived GMPs” 
(ivGMPs).  
 
 
 
 
  
 
 
 
 
 
 
Figure 6-2: In vitro derivation of GMPs (ivGMPs) from BM-derived preGMPs. 
(a) FACS gating scheme to sort BM-derived GMPs and preGMPs. GMPs are gated as linneg c-kitpos Sca-1neg 
CD16/32hi, preGMPs are gated as linneg c-kitpos Sca-1neg CD16/32neg/lo CD105neg CD150neg. (b) GMPs or 
preGMPs were cultured in presence of 100ng/ml SCF and Flt3L for 3 days and then analyzed for CD16/32 and 
MacI expression via flow cytometry. CD16/32hi MacIneg ivGMPs are LysM-negative and therefore uncommited. 
Representative FACS plots are shown. 
 
To assess the lineage potential of ivGMPs, cels were FACS purified and compared 
side by side with freshly isolated BM-derived GMPs in liquid or semi-solid cultures with 
diferent cytokine mixtures. Lineage output was determined after four to five days by flow 
cytometry (Figure 6-3a, macrophage (M) = MacIpos F4/80pos Ly6Gneg, granulocyte (G) = 
MacIpos F4/80neg Ly6Gpos) or by scoring colonies (Figure 6-3b). In permissive liquid culture 
condition, containing serum, SCF, IL3, TPO, and EPO, GMPs and ivGMPs produced similar 
proportions of M (22±0.4% and 24.9±1.6%, respectively) and G (47.4±7.2% and 43.8±6.4%, 
respectively (mean±SEM). Likewise, lineage output of GMPs and ivGMPs cultured in 
serum, M-CSF, and G-CSF was similar (M: 34.6±0.9% and 37.1±3.6%, respectively; G: 
37.7±3.3% and 35.1±1.6%, respectively (mean±SEM) (Figure 6-3a). Additionaly, lineage 
output in permissive colony assays was comparable for GMPs and ivGMPs (M: 15.6±2% and 
17±5%, respectively; G: 60.5±2.3% and 54.5±6.1%, respectively; GM: 14.2±0.8% and 
17±1%, respectively (mean±SEM) (Figure 6-3b). Colectively, the lineage potential of 
ivGMPs and GMPs was comparable in al conditions tested, indicating that ivGMPs are 
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identical to GMPs in al relevant aspects tested. This makes ivGMPs an appropriate celular 
model system to study effects of overexpressed proteins in a normal bipotent celular context. 
 Successfuly seting up the transplantation approach to obtain BM derived C57BL/6 
MCSFR-/- progenitors in combination with the in vitro generation of GMPs was a prerequisite 
to properly analyze MCSFR function described in the folowing section. 
 
 
  
 
 
                       
 
 
 
 
 
 
 
 
Figure 6-3: GMPs and ivGMPs have similar lineage potential. 
(a) Freshly isolated GMPs ivGMPs were cultured in either SCF, IL3, TPO, EPO, 10%FCS or M-CSF, G-CSF, 
10%FCS and analyzed for macrophage (MacIpos F4/80pos Ly6Gneg) and granulocyte (MacIpos F4/80neg Ly6Gpos) 
output via flow cytometry after 4-5 days (n=3-6). (b) Fresh BM-derived GMPs and ivGMPs were cultured in 
colony assay medium (M3434 containing SCF, IL3, IL6, and EPO). After 5-7 days, colonies were enumerated 
and identified according to morphology (n=3). Bars represent mean percentage±SEM. An unpaired Student’s t-
test did not detect a significance diference between means of the two groups. 
 
 
 
6.2 Investigating the role of individual MCSFR tyrosine residues in M-CSF-mediated 
cel fates 
 
 The MCSFR has eight described functional tyrosine residues that upon M-CSF 
binding and receptor dimerization are auto-transphosphorylated to initiate several 
downstream signaling pathways that mediate the pleiotropic actions of M-CSF. Other 
phosphorylated sites in the MCSFR activating signaling pathways have so far not been 
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described, which is why we focused on the eight known functional tyrosine residues. To gain 
insight into the function of individual MCSFR tyrosines, we re-introduced MCSFR 
constructs lacking individual or several tyrosine residues (Yu et al. 2008) into MCSFR-/- 
preGMPs by lentiviral transduction and analyzed how the lack of tyrosines afects M-CSF-
mediated diferentiation of ivGMPs (Figure 6-4a). We chose to do so by time lapse imaging, 
which alows simultaneous detection and quantification of several cel fate parameters 
influenced by M-CSF, including cel death, proliferation, and macrophage diferentiation. 
 
 
 
 
 
 
 
 
Figure 6-4: Experimental strategy to produce and analyze MCSFR-/- ivGMPs rescued with MCSFR 
mutants. 
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(a) Eight weeks post transplantation of W41 mice with MCSFR-/- fetal liver cells (according to Figure 6-1), 
donor-derived MCSFR-/- preGMPs were FACS purified and transduced with lentiviruses (Figure 5-1) encoding 
MCSFR mutants lacking none (Ywt) or individual to all (YEF) tyrosine residues. Three days post infection, 
successfully transduced ivGMPs were isolated by FACS by means of an anti-MCSFR (CD115) antibody and the 
lentiviral Venus reporter. Sorted cells were then time-lapsed imaged during M-CSF-mediated differentiation and 
retrospectively analyzed using self-developed software. (b) Representative FACS plots showing MCSFR 
expression on untransduced MCSFR-/- (used for setting the negative gate), wild type (used for setting the 
positive gate according to endogenous levels), and MCSFR-/- cells rescued via lentiviral transduction. (c) 
MCSFR+/+ cells and MCSFR-/- cells rescued with the wild type receptor (Ywt) generate MacIpos F4/80pos 
macrophage colonies in response to M-CSF (20ng/ml). Pictures are representative snapshots from a time-lapse 
experiment. Cytospins confirmed macrophage morphology (representative pictures are shown).  
 
MCSFR-/- ivGMPs were generated according to Figure 6-1 and 6-2. Successfully 
transduced ivGMPs were FACS purified using an anti-MCSFR antibody and a fluorescent 
marker included in the lentiviral construct. To avoid potential artifacts caused by receptor 
overexpression, only transduced cells with a similar MCSFR expression level as littermate-
derived MCSFR+/+ cells were sorted (Figure 6-4b). Transducing MCSFR-/- cells with the wild 
type MCSFR (Ywt) restored their capability to form M-CSF-induced macrophage colonies in 
liquid culture and methylcellulose, demonstrating that M-CSF-mediated survival, 
proliferation, and differentiation could be rescued (Figure 6-4c, 6-5, and data not shown). Of 
note, the high survival and differentiation rates of C57BL/6 ivGMPs (Figure 6-5b, c, d) 
demonstrate that the MCSFR antibody (clone AFS98 (Sudo et al. 1995)) used for sorting 
transduced ivGMPs carrying endogenous levels of MCSFR is neither detrimental to cell 
survival nor colony formation. 
 Next, MCSFR-/- ivGMPs rescued with different MCSFR single tyrosine mutants 
(Figure 6-5a) were exposed to M-CSF and time-lapse imaged for several days during their 
differentiation. Using self-developed software, colonies were retrospectively tracked and 
their M-CSF-induced behavior analyzed at the single cell level (Figure 6-4a).  
 First, we looked at the contribution of individual MCSFR tyrosine residues to M-
CSF-mediated survival and proliferation. As GMPs are usually committed after two 
consecutive divisions (Rieger et al. 2009), we quantified the percentage of dying and 
proliferating cells in the first two generations (Figure 6-5b, c). As expected, virtually all cells 
reconstituted with a MCSFR lacking all eight tyrosine residues (YEF) died within the first 
two generations. In contrast, cells rescued with the wild type MCSFR (Ywt) were not 
significantly different in terms of survival and proliferation rates as compared to C57BL/6 
wild type control cells (n.s., Student’s t-test). This demonstrates that the rescue of MCSFR-/- 
cells by reintroducing MCSFR-variants is principally feasible and functionally efficient 
during a time window in which lineage commitment usually occurs. Mutation of single 
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tyrosine residues had varying efects on colony survival, but only those of Y706, Y721, and 
Y807 resulted in significantly lower survival and proliferation as compared to Ywt (p<0.05, 
Student’s t-test) (Figure 6-5b, c). Although being quite heterogeneous in general, none of the 
single tyrosine mutated receptors drasticaly influenced the average cel cycle times of non-
adherent (i.e. non-macrophages) cels as compared to Ywt and C57BL/6 controls (Figure 6-
5e). Moreover, the frequency distribution of cel cycle times was not significantly diferent 
compared to Ywt (n.s., Mann-Whitney U test).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-5: Time lapse imaging reveals contribution of single MCSFR tyrosines to M-CSF-mediated 
effects. 
(a) MCSFR mutants analyzed. Ywt served as a positive control, YEF as a negative control. Other YF mutants 
lack indicated single tyrosine residues. (b) Percentage of cels dying within the first two generations, after which 
cels are usualy commited. (c) Proliferating colonies were quantified as starting cels that underwent at least 
two consecutive cel divisions. (d) Differentiating colonies were scored as colonies that gave rise to MacIpos 
F4/80pos adherent cels. Bars represent mean±SEM. Each data point represents one movie. Total movies/colonies 
analyzed: Bl6 (6/194), Ywt (7/246), Y544F (3/57), Y559F (4/77), Y697F (3/54), Y706F (2/49), Y721F (5/156), 
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Y807F (4/178), Y921F (5/131), Y974F (2/58), YEF (4/147). An unpaired Student’s t-test was used to determine 
the significance of the difference between means of two groups. *<0.05, **<0.01, ***<0.001 compared to Ywt. 
(e) Cell cycle times of non-adherent cells. The 1st generation was omitted due to unknown cell cycle length 
before the start of imaging. Box plots represent 5-95% confidence intervals (whiskers), population medians 
(horizontal line), and population means (+). Average cell cycle times (hours±SEM) are written. Total 
movies/cells analyzed: Bl6 (6/602), Ywt (7/616), Y544F (3/155), Y559F (4/292), Y697F (3/113), Y706F 
(2/101), Y721F (5/453), Y807F (4/314), Y921F (5/263), Y974F (2/104). A Mann-Whitney U test did not detect 
significant differences in the frequency distribution of cell cycle times compared to Ywt.  
  
 Next, we looked at the efficiency of single tyrosine-mutated MCSFRs to rescue 
macrophage differentiation. Macrophages were scored as cells that adhered and expressed the 
markers MacI and F4/80 as detected by live in-culture antibody staining (Eilken et al. 2011) 
(Figure 6-4c). Notably, all MCSFR-/--derived ivGMPs produced less macrophage colonies 
than the C57BL/6 control, irrespective of which receptor was re-introduced (including Ywt) 
(Figure 6-5d). Colonies that did not form macrophages either died prior to differentiation, or 
produced cells that were not classified as macrophages according to the above mentioned 
criteria (data not shown). Compared to Ywt, the mutation of Y559, Y721, and Y807 resulted 
in significantly fewer macrophage colonies (75%, 58%, and 37% of Ywt level, respectively 
(p<0.05, Student’s t-test)).  
 As mutation of Y807 led to a marked reduction of survival, it is difficult to tell 
whether a potential differentiation defect might be masked through cells dying before being 
able to differentiate. To circumvent this, we used a bcl2-overexpressing mouse line (Ogilvy 
et al. 1999) that we crossed into the MCSFR-deficient background. Bcl2 is an anti-apoptotic 
protein whose overexpression can prolong cytokine-independent survival of cells (Ogilvy et 
al. 1999). Bcl2-overexpressing MCSFR-/- ivGMPs rescued with the Y807F mutant survived 
comparably to the Ywt rescue. However, most cells carrying the Y807F MCSFR were still 
incapable to differentiate into macrophages, indicating that Y807 is indeed required for both 
survival and differentiation (data not shown). Furthermore, Y807-transduced cells mainly 
produced colonies that resembled granulocytic cells (data not shown).  
In summary, the varying effects single MCSFR YF mutants had on survival, 
proliferation, and differentiation indicate that individual tyrosines are functionally involved in 
regulating these cell fates in primary GMPs. However, none of the individual YF mutants 
totally abrogated survival or differentiation, pointing towards high functional overlap among 
the single tyrosine residues.  
 In similar experiments, YEF add-back (AB) mutants were analyzed. In these mutants, 
all eight tyrosine residues are mutated but the one or two indicated in the name (Figure 6-6a). 
Single tyrosine AB mutants partially rescued M-CSF-mediated survival when compared to 
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the ful mutant YEF. Yet, in al cases, over 50% of cels died within the second generation 
(Figure 6-6b). Compared to the levels of Ywt, adding back single Y544, Y721, or Y807 
partialy rescued M-CSF-mediated proliferation to 12%, 37%, or 26% of Ywt, respectively 
(Figure 6-6c). However, adding back single Y544, Y721, or Y807 did not significantly rescue 
macrophage diferentiation compared to YEF (n.s., Student’s t-test) (Figure 6-6d). Adding 
back single Y559 improved proliferation and differentiation to 64% and 50% of Ywt level, 
respectively, indicating that this tyrosine residue plays a major role in transmiting 
proliferation- and diferentiation-inducing signaling.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-6: Time-lapse imaging of add-back mutans reveals Y559 to be suficient for M-CSF-mediated 
effects. 
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(a) MCSFR add-back (AB) mutants analyzed. Ywt and YEF served as positive and negative control, 
respectively. AB mutants lack all but the indicated tyrosine residue(s). (b) Percentage of cells dying within the 
first two generations, after which cells are usually committed. (c) Proliferating colonies were quantified as 
starting cells that underwent at least two consecutive cell divisions. (d) Differentiating colonies were scored as 
colonies that gave rise to MacIpos F4/80pos adherent cells. Bars represent mean±SEM. Each data point represents 
one movie. Total movies/colonies analyzed: Bl6 (6/194), Ywt (7/246), Y544AB (2/69), Y559AB (3/139), 
Y721AB (2/67), Y807AB (4/168), Y559/807AB (5/179), YEF (4/147). An unpaired Student’s t-test was used to 
determine the significance of the difference between means of two groups. *<0.05, **<0.01, ***<0.001 
compared to Ywt (b) or YEF (c+d). (e) Cell cycle times of non-adherent cells. The 1st generation was omitted 
due to unknown cell cycle length before the start of imaging. Total movies/cells analyzed: Bl6 (6/602), Ywt 
(7/616), Y559/807AB (5/502). (f) Onset of F4/80 expression as detected via live in-culture antibody staining. 
Total movies/cells analyzed: Bl6 (4/79), Ywt (4/54), Y559/807AB (3/35). Box plots represent 5-95% 
confidence intervals (whiskers), population medians (horizontal line), and population means (+). A Mann-
Whitney U test did not detect significant differences in the frequency distribution of cell cycle times and F4/80 
onsets compared to Ywt.   
 
 Adding back Y807 in addition to Y559 (Y559/807AB) almost completely restored 
Ywt levels of survival, proliferation (to 95%), and differentiation (to 78%). Furthermore, 
cells rescued with Y559/807AB had similar cycling times as cells rescued with Ywt 
(13.4±0.2 for Ywt and 14.5±0.3h for Y559/807AB (mean±SEM)) (Figure 6-6e) and the 
macrophage differentiation kinetics, read out by onset of F4/80 expression, did not differ 
significantly (n.s., Mann-Whitney U test) (Figure 6-6f).     
Using the aforementioned bcl2 overexpressing mouse background to prolong cytokine-
independent survival confirmed that Y807 or Y721 alone were not sufficient for M-CSF-
mediated differentiation (data not shown).  
Taken together, while single mutations proved to be limited in assessing the function 
of individual tyrosine residues, adding back tyrosines to a complete mutant background 
revealed Y559 to be sufficient for M-CSF-mediated survival and macrophage differentiation. 
The addition of Y807 alongside Y559 added to this effect, while by itself Y807 had little 
rescue capacity, which is in line with its proposed role in structural activation of the MCSFR 
rather than activating cell fate-mediating signaling pathways. 
 
 
 
6.3 Manipulating MCSFR signaling using small molecules 
 
 The above described receptor mutant screening indicated an important role for Y559 
in M-CSF-induced differentiation and hence indirectly suggests that the lineage-instructive 
signal can be transmitted via the same tyrosine. Y559 is well described to activate members 
of the SFKs, which in turn can activate Akt and MAPK signaling. With this insight, we 
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sought out to manipulate signaling downstream of the MCSFR by using smal molecule 
inhibitors in order to identify pathways involved in lineage instruction and diferentiation. To 
that end, we cultured wild type BM-derived GMPs in instructive or permissive conditions, 
either in presence or absence of pathway inhibitors. A list of inhibitors and concentrations 
used can be found in Table 6-1. Cultures of cels were either analyzed by flow cytometry 
after 4-5 days (Figure 6-7a) or imaged continuously by time-lapse microscopy during their 
diferentiation. 
 
       Table 6-1: Used inhibitor concentrations 
Inhibitor Target Concentration 
 
SU6656 
Ly294002 
 
SFK 
PI3K 
 
2µM 
50µM 
SB203580 p38 10µM 
PD0325901 
NBD 
MEK 
IKK 
1µM 
50µM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-7: Inhibiting various signaling pathways does not block M-CSF-instructed diferentiation. 
(a) Experimental strategy. Freshly isolated GMPs were starved in presence of signaling pathway inhibitors for 
1h before adding M-CSF. After 4 days of culture in 5ml FACS tubes, cels were analyzed by flow cytometry. 
The FSC/SSC gate was used to determine cel survival. Macrophage output was determined using macrophage 
marker F4/80. (b) Fraction of living cels after 4 days of culture, as determined via FSC/SSC gating. Note: 
survival of cels in presence of NBD could not be determined due to inhibitor precipitates falsifying the 
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FSC/SSC gate used to assess survival. (c) Fraction of F4/80pos macrophages after 4 days of culture. Bars 
represent mean±SEM. (n=3-8 experiments). An unpaired Student’s t-test was used to determine the significance 
of the difference between means of two groups. *<0.05, **<0.01, ***<0.001 compared to DMSO vehicle 
control.     
 
 Compared to M-CSF (no inhibitor) or DMSO vehicle control cultures, significantly 
fewer cells survived in presence of SFK (SU6656) or ERK (PD0325901) inhibitor (81% or 
65% survival of DMSO vehicle control, respectively) (p<0.05, Student’s t-test) (Figure 6-7b). 
Yet, in presence of these inhibitors surviving cells formed equal portions of macrophages 
compared to control cultures, indicating that lineage decision was not affected. Presence of a 
PI3K inhibitor (Ly294002) had no effect on M-CSF-mediated survival and differentiation. 
Inhibition of MAPK p38 abrogated cell survival, preventing assessment of macrophage 
differentiation. Virtually no cells survived when inhibiting PI3K and SFKs simultaneously. 
Blocking of NFκB signaling, a potential candidate pathways downstream of Akt, via NBD 
seemed to have no effect on differentiation. 
To more directly assess the effect of cell signaling inhibitors on lineage choice, we 
made use of aforementioned LysM:EGFP mice, which express EGFP when cells commit to 
either the M or G lineage. Time-lapse movies of LysM:EGFP GMPs cultured in M-CSF in 
absence or presence of inhibitors SU6656 (SFKs) or NBD (NFκB) revealed no differences in 
cell survival or the fraction of cells committing and differentiating into macrophages, when 
compared to the DMSO vehicle control. Similarly, long-term imaging of LysM:EGFP GMPs 
cultured in both M-CSF and G-CSF either containing DMSO (vehicle control) or SU6656 
(SFKs) revealed no inhibitor-dependent defect in survival frequency, lineage commitment, or 
differentiation into either macrophages or granulocytes (data not shown).  
 We repeated the inhibitor experiments in permissive culture conditions (Figure 6-8a). 
None of the tested inhibitors showed effects on the survival of GMPs in permissive cytokine 
condition (Figure 6-8b). Notably, this also held true for the p38 inhibitor and the PI3K/SFK 
inhibitor combination, demonstrating that the survival defects observed with these inhibitors 
were M-CSF specific. Inhibition of PI3K reproducibly led to a ~50% decrease of 
immunophenotypically defined macrophages as compared to the DMSO control (Figure 6-8c, 
d). However, the output of granulocytes was unaffected. Cultures containing p38 inhibitor led 
to a decrease in granulocytic (down by 28% compared to control) and an increase in 
macrophage (up by 12%) output. Inhibiting ERK led to an increase in the macrophage 
compartment by 34% and to a decrease of granulocytic output by 9% compared to controls. 
The SFK inhibitor SU6656 had no effect on differentiation by itself, but seemed to decrease 
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granulocytic output in combination with the PI3K/Akt inhibitor (by 18% compared to 
control) while no further decrease in macrophage diferentiation was observed as compared 
to the PI3K inhibitor alone (Figure 6-8c).  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6-8: Inhibiting various signaling pathways in permissive cytokine conditions has varying effects on 
M vs. G output. 
(a) Experimental strategy. Freshly isolated GMPs were starved in presence of signaling pathway inhibitors for 
1h before adding cytokines (SCF, IL3, TPO, EPO, and 10% FCS). After 5 days of culture in 5ml FACS tubes, 
cels were analyzed by flow cytometry. The FSC/SSC gate was used to determine cel survival. Macrophage and 
granulocyte output was determined using lineage specific markers F4/80 and Ly6G, respectively. (b) Fraction of 
living cels after 5 days of culture, as determined via FCS/SSC gating. (c) Fraction of F4/80pos Ly6Gneg 
macrophages and F4/80neg Ly6Gpos granulocytes after 5 days of culture. Bars represent mean±SEM (n=3-6 
experiments). An unpaired Student’s t-test was used to determine the significance of the difference between 
means of two groups. *<0.05, **<0.01 compared to no inhibitor control. (d) Representative FACS plot showing 
reduction of macrophage output in the presence of PI3K inhibitor Ly294002. Numbers reflect average 
percentage from 5-6 experiments. 
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In summary, none of the tested inhibitors had an efect on the M-CSF-instructed 
diferentiation towards macrophages. Blocking p38 signaling resulted in cel death, indicating 
that M-CSF-induced survival is mediated via p38, but simultaneously rendering it impossible 
to reveal potential effects on M-CSF diferentiation. Simultaneous inhibition of PI3K and 
SFKs synergisticaly prevented cel survival. Both survival defects seem to be specific for M-
CSF, as cels survived normaly in presence of the same inhibitors in permissive conditions. 
A variety of efects on the macrophage vs. granulocyte output could be observed in 
permissive conditions with the inhibitors tested, with Ly294002 being the most notable by 
leading to a decrease in macrophage output by 50%. Yet, none of the inhibitors tested totaly 
abrogated the diferentiation of GMPs to either one of the two lineages they can diferentiate 
into. 
As the MCSFR residue Y559 proved to be suficient for M-CSF-instructed 
macrophage diferentiation, we next cultured MCSFR-deficient ivGMPs rescued with Ywt or 
the Y559/807AB mutant in M-CSF in presence of the SFK inhibitor SU6656 and serum. In 
control cultures (M-CSF and serum only), cels carying Ywt or Y559/807AB were able to 
diferentiate into macrophages as shown earlier. In contrast, virtualy no cels transduced with 
the Y559/807 MCSFR diferentiated into macrophages in presence of the SFK inhibitor, 
while cels rescued with Ywt were stil able to do so despite the presence of SFK inhibitor, 
similarly to what we observed with wild type GMPs (Figure 6-9). While the survival of cels 
 
Figure 6-9: Inhibition of SFKs prevents MCSFR Y559/807AB-mediated macrophage diferentiation. 
MCSFR-/- ivGMPs rescued with either Ywt or Y559/807AB were cultured in M-CSF and 10% FCS in absence 
or presence of SFK inhibitor SU6656 (2µM). Representative images are stils (~day 4) from a time-lapse 
imaging experiment with live antibody staining against MacI and F4/80. The nuclear membrane-tagged Venus 
stems from the virus used to transduce MCSFR-/- cels. Y559/807AB cels cultured in presence of SU6656 
mainly generate MacIpos F4/80neg cels with ring/horseshoe-shaped nuclei (zoom), resembling granulocytes. 
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transduced with the Y559/807AB MCSFR decreased ~20% in presence of SU6656 compared 
to Ywt and control cultures, most surviving colonies seemed to differentiate into MacIpos 
F4/80neg cells with granulocyte-typical ring/horseshoe-shaped nuclei (Figure 6-9 and data not 
shown). This demonstrates that Y559 can transmit the M-CSF lineage-instructive signal 
through SFKs. 
 
 
 
6.4 Manipulating MCSFR signaling through loss and gain of function mutants 
 
 Complementary to the small molecule approach, we sought out to manipulate MCSFR 
downstream signaling pathways by overexpressing either dominant-negative (DN) or 
constitutive-active (CA) variants of signaling proteins. With regards to the MCSFR mutant 
screening, which indicated a role of SFKs in the transmission of MCSF-induced lineage 
instruction, we chose to investigate different SFK members (c-Src, Fyn, Lyn, and Hck) and 
their potential downstream targets (Akt, NFκB). Furthermore, we included STAT3 for being 
a major mediator of G-CSF-induced signaling. To this end, we made use of the previously 
established in vitro differentiation system, generating ivGMPs from preGMPs (Figure 6-2). 
Similarly to the screening of MCSFR mutants, preGMPs were transduced with DN or CA 
signaling molecules via lentiviral vectors, while differentiating into ivGMPs. Transduced 
ivGMPs were then sorted and cultured in permissive cytokine conditions. After five days, 
cultures were analyzed for skewed lineage output by flow cytometry (Figure 6-10a).  
 None of the analyzed CA or DN mutants had a detrimental effect on cell survival 
(Figure 6-10b). Untransduced and empty vector controls (Venus control) were 
indistinguishable in their lineage output with ~25% M and ~50% G. All mutant proteins 
tested led to a decrease in granulocyte output. In sharp contrast, only overexpression of 
constitutive active Akt, constitutive active c-Src, and wild type p65 resulted in significantly 
increased macrophage output, raising it by 1.8-, 2.1-, and 2.7-fold compared to Venus 
control, respectively (p<0.05, Student’s t-test) (Figure 6-10c, d). As survival rates were not 
affected by the overexpression of these signaling proteins, the observed lineage skewing 
points towards an instructive effect on the lineage decision, rather than a selective 
mechanism. Alternatively, altered proliferation could also cause an increase in lineage output. 
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Figure 6-10: Overexpression of signaling mutants in ivGMPs indicates involvement of c-Src and NFκB in 
macrophage diferentiation in vitro. 
(a) Experimental strategy. preGMPs were freshly isolated, cultured in 100ng/ml SCF and Flt3L while being 
transduced with lentiviruses encoding variants of signaling molecules (constitutive active (CA) or dominant 
negative (DN)). After 3 days transduced ivGMPs were sorted and cultured in permissive cytokine conditions 
(SCF, IL3, TPO, EPO, and 10% FCS). After 5 days in culture, cels were analyzed for macrophage and 
granulocyte output by flow cytometry using lineage specific markers F4/80 and Ly6G, respectively. The 
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FSC/SSC gate was used to determine cell survival. (b) Fraction of living cells after 5 days of culture, as 
determined via FSC/SSC gating. (c) Fraction of F4/80pos Ly6Gneg macrophages (M) and F4/80neg Ly6Gpos 
granulocytes (G) after 5 days of culture. Bars represent mean±SEM. (n=3-7 experiments). An unpaired 
Student’s t-test was used to determine the significance of the difference between means of two groups. *<0.05, 
**<0.01, ***<0.001 compared to Venus control. Note: significance for differences in G output is not annotated, 
as all overexpressed signaling proteins seemed detrimental to it. (d) Representative FACS plot showing increase 
in macrophage output when cells were transduced with constitutive active (CA) c-Src. Numbers reflect average 
percentage from 6 experiments. Cytospin of sorted F4/80pos Ly6Gneg cells revealed macrophage morphology 
(representative picture).      
 
Noteworthy, constitutive active mutants of other SFKs Fyn, Lyn, and Hck did not lead to 
significantly increased macrophage output and neither did STAT3 variants. Unexpectedly, 
dominant negative variants of Akt and c-Src had no effect on M output.        
 In order to have a more quantitative readout regarding the M vs. G output, transduced 
ivGMPs were alternatively cultured in permissive colony assays (Figure 6-11a). To make 
colony scoring easier, lineage-specific live antibody staining was successfully applied to 
these cultures (Figure 6-11b). Complementing the results obtained from liquid culture assays, 
overexpression of constitutive active Akt, constitutive active c-Src, and wild type p65 
resulted in an increase in macrophage colonies and a concomitant decrease in granulocyte 
colonies (Figure 6-11c). In the case of p65, virtually no G colonies could be detected. SFK 
members Fyn, Lyn, and Hck, as well as STAT3 variants, had no major effect on colony types 
and frequencies as compared to controls. Of note, compared to liquid cultures (Figure 6-10c), 
a general decrease in G colonies was not observed. Furthermore, colony sizes did not seem to 
differ between the different overexpressed proteins tested, indicating that proliferation times 
were not affected (data not shown). 
 In conclusion, overexpression of constitutive active c-Src, constitutive active Akt, and 
wild type p65 resulted in skewing of the lineage output of bipotent ivGMPs towards 
macrophages at the expense of granulocytes. As survival and proliferation rates did not seem 
to be affected, this suggests that the effect occurred at the level of lineage decision.   
 
 
 
6.5 Detecting activity of signaling pathways in single living cells 
 
 Besides monitoring cellular behavior, there is also the need to continuously quantify 
dynamic molecular behavior, such as signaling activity, at the single cell level over time. 
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Figure 6-11: Overexpression of signaling mutants in ivGMPs confirms involvement of c-Src and NFκB in 
macrophage diferentiation in vitro. 
(a) Experimental strategy. preGMPs were freshly isolated, cultured in 100ng/ml SCF and Flt3L while being 
transduced with lentiviruses encoding variants of signaling molecules (constitutive active (CA) or dominant 
negative (DN)). After 3 days transduced ivGMPs were sorted and cultured in permissive colony assay medium 
(M3434, containing SCF, IL3, IL6, and EPO). After 5-7 days in culture, colonies were enumerated and 
identified using lineage specific markers (F4/80 for macrophages and Ly6G for granulocytes). (b) 
Representative examples of colony types identified with the help of live in-culture antibody staining. (c) 
Quantification of colony types after 5-7 days in culture. Bars represent mean±SEM (n=3-6 experiments). An 
unpaired Student’s t-test was used to determine the significance of the difference between means of two groups 
(only shown for M). *<0.05, **<0.01, ***<0.001 compared to Venus control. 
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Strength and timing of signaling events are important to fuly understand their functional 
consequence on cel fate. Fluorescent biosensors visualize signaling activity in living cels 
and therefore alow to link dynamic signaling behavior to future cel fate. To detect M-CSF-
induced signaling events in live cels, we sought out to establish the use of fluorescent 
biosensors in primary myeloid progenitors. 
  Biosensors detecting different signaling pathways were gathered and cloned into 
lentiviral vectors (Table 8-3, 8-4 in Appendix). To test the general applicability of biosensors 
with M-CSF, we first utilized a sensor for PI3K signaling (Haugh et al. 2000), which is wel 
described to be activated by M-CSF. The PI3K sensor is based on the pleckstrin homology 
(PH) domain of Akt, which specificaly binds PI3K-produced PIP3 in the plasma membrane. 
As a result of PIP3 production, the PI3K sensor translocates to the plasma membrane, which 
is visualized by the fluorescent protein Venus fused to the PH domain. We transduced 
monocytic RAW 264 cels, which express the MCSFR endogenously, with the PI3K sensor. 
Stimulation of the cels with M-CSF resulted in a rapid and transient translocation of the 
sensor from the nucleus and cytoplasm to the plasma membrane, demonstrating that M-CSF 
activates PI3K signaling in this cel line (Figure 6-12a). Next, we repeated the experiment 
using freshly isolated GMPs. Similar to the monocytic cel line, the sensor rapidly and 
transiently translocated to the plasma membrane (Figure 6-12b), confirming that M-CSF 
activates PI3K signaling in primary myeloid progenitors. Another translocation-based sensor 
tested consists of the C1 domain of protein kinase C (PKC), which detects diacylglycerol 
production in the plasma membrane and thereby indirectly activity of PLC (Oancea et al. 
1998). In GMPs the sensor translocated upon chemical stimulation with a phorbol ester (a 
diacylglycerol analogue), but not upon M-CSF stimulation (data not shown), suggesting that 
PLC is not activated by M-CSF. 
          
               
Figure 6-12: Detection of rapid and transient activation of M-CSF-induced signaling in living cels. 
(a+b) Time-lapse microscopy of (a) live monocytic RAW 264 cels and (b) primary GMPs transduced with a 
biosensor for PI3K activation. Stimulation with M-CSF results in rapid and transient translocation of the sensor 
from cytosol and nucleus to the plasma membrane, indicating activation of the pathway. Time lapse pictures 
were taken every 1-2 minutes. Representative timepoints are shown.  
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 Collectively, this demonstrates the feasibility of using biosensors to detect 
intracellular signaling events in primary progenitors at single cell sensitivity and high 
temporal resolution without losing single cell identity. 
 
 
 
6.6 Transcriptional program activated by M and G-CSF 
 
 In order to get insight into the transcriptional program activated by M- and G-CSF, 
we carried out microarray analyses. We took advantage of aforementioned mouse model, 
which expresses EGFP under the lysozyme M promoter. It has been shown previously, that 
cells expressing GFP in this model are unilineage committed either to macrophages or 
granulocytes (Rieger et al. 2009). We FACS-purified GMPs from these mice and cultured 
them with either M- or G-CSF for different lengths of time (Figure 6-13a). Samples were 
collected at two, twenty-four, and forty-eight hours after cytokine addition in order to capture 
and discriminate between early and late target genes. Twenty-four and forty-eight hour 
samples were sorted according to LysM:EGFP expression (low and high) by FACS to 
distinguish between recently committed (GFP low) and further differentiated cells (GFP hi) 
(Figure 6-13b). RNA from all samples was isolated and subjected to microarray analysis. 
 Figure 6-13c shows the global changes in gene expression along the two time series 
and differences between the corresponding timepoints. Very early (2h timepoint) genes 
activated by M- and G-CSF seem to extensively overlap. Gene expression after 48h of 
stimulation with M- or G-CSF was more similar than after 24h of stimulation, which suggests 
that the biggest differences between M- and G-CSF gene expression patterns exist during 
lineage commitment. Noteworthy, it has been shown before that on a transcriptional level, 
granulocytes (neutrophils) and macrophages are relatively similar (Sasmono et al. 2007). 
Indeed, many genes associated with macrophage differentiation were also upregulated upon 
G-CSF stimulation, such as Klf4, Emr1 (F4/80), and Csf1r (MCSFR) (Figure 6-14a). Genes 
specifically upregulated by M-CSF included Dab2 and Dok2, two negative regulators of SFK 
and MAPK signaling, respectively (Shinohara et al. 2005, Zhou et al. 2003) (Figure 6-14b). 
G-CSF-specific genes included Stat3 and Socs3, two well known molecules involved in G-
CSF signaling (Figure 6-14c). Moreover Socs3 is known to be upregulated upon G-CSF 
stimulation (Geijn et al. 2004). 
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Figure 6-13: LysM:EGFP mice as a tool to dissect M- and G-CSF-mediated gene expression involved in 
lineage instruction. 
(a) Experimental scheme. GMPs were sorted from LysM:EGFP mice and cultured either in M-CSF or G-CSF. 
After 2 h cels were directly colected for RNA isolation and subsequent gene expression analysis. 24h and 48h 
samples were FACS purified according to GFP expression (low and high), subjected to RNA extraction and 
subsequent gene expression analysis. (b) Representative FACS plots of 24h and 48h samples sorted according to 
low or high GFP expression. LSK cels served as negative gating control. Numbers represent average percentage 
from 3 experiments. (c) Global gene expression changes along M- and G-CSF mediated diferentiation. 
Numbers indicate genes expressed at least 1.5-fold higher or lower than in the compared condition. Heat maps 
were generated with GATE (MacArthur et al. 2010). 
 
Next, we clustered diferentialy expressed genes according to their expression 
kinetic. This resulted in seven distinct paterns. For M-CSF stimulation, paterns I-II 
included genes upregulated throughout the time series, while paterns V-VI consisted of 
downregulated genes. Patern IV included genes that were early up- and then downregulated 
(Figure 6-15a). For G-CSF stimulation, paterns I-IV consisted of genes being upregulated, 
while paterns V-VI consisted of genes being downregulated (Figure 6-15b). GO-term 
analysis of the diferent clusters using the online platform DAVID (Huang et al. 2009) 
revealed that most genes within al clusters were associated with metabolic processes (Table 
8-1 and 8-2 in Appendix). To reveal potential gene signatures associated with specific 
signaling pathways, we analyzed the diferent clusters using Genomatix pathway system 
(GePS), an online-based platform to identify enriched gene sets in gene lists. 
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Figure 6-14: Many macrophage-associated genes are also upregulated by G-CSF stimulation. 
(a) Examples of genes typicaly associated with macrophage diferentiation that are also upregulated by G-CSF. 
(b) Examples of genes specificaly upregulated by M-CSF. (c) Examples of genes specificaly upregulated by G-
CSF.  
 
M-CSF-regulated genes within patern I and I were significantly enriched in Syk, NFκB, and 
MAPK gene sets and others (Figure 6-15c). M-CSF paterns II-VI did not include signaling 
pathway-associated gene sets. G-CSF gene expression paterns included, amongst others, 
STAT, Syk, Hck, Src, and NFκB (Figure 6-15d). 
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Figure 6-15: Transcriptional profiling of M-CSF- and G-CSF-mediated lineage instruction. 
(a+b) Clustering of genes according to their expression kinetics revealed 7 distinct paterns for (a) M-CSF 
stimulation and (b) G-CSF stimulation. (c+d) Analysis of paterns using online-based platform Genomatix 
pathway system (GePS) for (c) M-CSF and (d) G-CSF. Shown are only significantly enriched (p<0.05) gene 
sets associated with signaling pathways. Note: clusters not shown were not enriched in signaling pathway-
associated gene sets. Ploted are -ln(p-value) values. Syk: spleen tyrosine kinase; TLR: tol like receptor; 
MAPK: mitogen- activated protein kinase, PTP: protein tyrosine phosphatase non receptor type; Myd88: 
myeloid differentiation primary response 88; Hck: hemopoietic cel kinase; STAT: signal transducer and 
activator of transcription; PLD: phospholipase D; TRAF: TNF receptor associated factor; CK: casein kinase. 
  
Colectively, microaray analysis revealed that the overal M- and G-CSF-induced 
gene expression is very similar. Enrichment analysis of regulated genes indicate that 
SFK/Syk- and NFκB-signaling pathways are prominently activated upon M- and G-CSF 
stimulation. 
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and because constitutive active c-Src drove macrophage diferentiation, we performed RT-
qPCR to identify which SFK members are expressed in freshly isolated GMPs. Surprisingly, 
we were unable to detect c-Src. Expressed members were Hck, Fgr, Lyn, Fyn, Yrk, and Lck 
(Figure 6-17a). Immunostaining against p-SFK revealed that SFKs are expressed and 
activated at the protein level in freshly isolated steady-state GMPs (Figure 6-17b). 
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Figure 6-16: Most M-CSF-regulated genes associated with Src/Syk, MAPK, and NFκB signaling are 
upregulated after lineage commitment. 
(a) Al genes regulated by M-CSF (up and down) or (b) genes only upregulated by M-CSF were analyzed in 
GePS to extract significant gene sets. The corresponding genes within the gene sets were extracted and their 
expression ploted over time. 
 
 
 
 
 
Figure 6-17: Expression of SFKs in primary GMPs. 
(a) RT-qPCR against al known mammalian SFK members. (b) Immunostaining against active p-Src 
(representative picture showing a single optical section from confocal microscopy). Note: The antibody used is 
not SFK member-specific. 
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7 Discussion 
 
 GMPs can be instructed to differentiate into macrophages or granulocytes by 
stimulation with the hematopoietic cytokines M- and G-CSF, respectively (Rieger et al. 
2009). M- and G-CSF activate specific signaling pathways that mediate the pleiotropic 
actions of these cytokines and ultimately drive lineage differentiation. However, the 
abundance of activated signaling cascades makes it difficult to functionally link specific 
pathways to specific biological effects. The goal of this study was to better understand the 
involvement of individual activated signaling pathways in transmitting M-CSF-mediated 
responses, including survival, proliferation, lineage choice, and ultimately differentiation in 
primary myeloid progenitors.   
 
 
7.1 Analyzing MCSFR function in the correct cellular context 
 
Studies examining the role of individual receptor tyrosine residues in initiating 
specific signaling pathways and how these are connected to cellular fates have produced 
conflicting results. For example, depending on the cellular system and methods used, 
mutation of MCSFR Y559 was shown to enhance cell proliferation (Rohde et al. 2004), 
decrease proliferation (Takeshita et al. 2007, Yu et al. 2008), or have no effect on 
proliferation (Marks et al. 1999). Similarly, mutation of Y807 was shown to reduce cell 
proliferation (Takeshita et al. 2007, van der Geer & Hunter 1991), or enhance it (Bourette et 
al. 1995). Previous approaches investigating MCSFR structure/function often depended on 
myeloid cell lines or fibroblasts devoid of endogenous MCSFR expression (Bourette et al. 
1995, 1997; Bourgin et al. 2002, Liu et al. 2001, Mancini et al. 1997, van der Geer & Hunter 
1991, Wilhelmsen et al. 2002, Wolf et al. 2002) or on chimeric receptors consisting of 
extracellular and intracellular parts of different cytokine receptors (Faccio et al. 2007, 
Takeshita et al. 2007). Chimeric receptors were used when the experimental cells 
endogenously express the MCSFR, such as in the case of primary BM-derived macrophages. 
The extracellular domain of these chimeric receptors then allows triggering MCSFR 
signaling using a different ligand. However, a chimeric receptor may not behave exactly like 
a wild type full-length MCSFR: e.g. binding of a different ligand might not activate the 
cytoplasmic part of the MCSFR to an extent as the original ligand M-CSF would. Myeloid 
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cell lines are easy to cultivate and can be grown indefinitely, but their intracellular milieu is 
often (pre)leukemic and hardly reflects that of primary cells. Yet, cytokine-induced effects 
may only be initiated if the cell has the intracellular and molecular context required to 
correctly interpret the external stimulus. Cells that do not endogenously express the MCSFR 
might not express signaling molecules and/or transcription factors that are normally recruited 
or activated by the receptor. Similarly, chromatin structures of target genes and miRNAs 
might not be in the required configuration to elicit effects reflecting physiological responses.  
Moreover, expression levels of cytokine receptors might affect cytokine-mediated cellular 
outcomes, and molecular machineries mediating different cytokine effects may only be active 
or present during specific time windows of differentiation. All of these points likely explain 
the conflicting results obtained for single tyrosine signaling activation and concomitant 
consequences on cell fate. It is therefore critical to examine M-CSF-evoked signaling in the 
specific cell of interest, and if possible in cells of primary origin. On the contrary to myeloid 
cell lines, primary progenitor cells, which physiologically respond to and differentiate upon 
M-CSF exposure and therefore represent the appropriate cellular model system to study M-
CSF-induced signaling, are rare in numbers, difficult to obtain, and cannot be kept in culture 
for a great length of time, as isolated cells start differentiating as soon as they are placed in 
culture.  
Here, we established a system that allowed us to analyze the role of single MCSFR 
tyrosine-evoked signaling in transmitting M-CSF-mediated effects in uncommitted, primary 
BM-derived progenitors that normally express endogenous MCSFR, avoiding the use of 
chimeric receptors. To this end, we utilized a MCSFR-deficient strain (Dai et al. 2002). 
Because the MCSFR-/- genotype is neonatally lethal, we isolated fetal liver cells at E14.5 and 
transplanted them into W41 recipient mice. Donor-derived MCSFR-/- hematopoietic 
precursors isolated from W41 recipient mice were subsequently lentivirally transduced with 
MCSFR transgenes carrying the desired tyrosine mutations. The in vitro differentiation step 
starting with BM-derived preGMPs generated GMPs that were identical to fresh BM-derived 
GMPs in their lineage output and also in cell cycling times as determined in time lapse 
movies. We therefore assume that the in vitro generated GMPs closely resemble their primary 
BM-derived equivalent and that M-CSF-mediated effects observed in in vitro-derived GMPs 
hold also true for primary GMPs. To analyze individual MCSFR tyrosine residues in this 
cellular model system, we re-introduced MCSFR mutants lacking individual or several 
tyrosines and then exposed the cells to M-CSF. Because cells are lacking endogenous wild 
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type MCSFR due to the genetic knock out background, M-CSF-induced effect can only be 
initiated via the re-introduced mutant MCSFR. To our knowledge, no one has analyzed 
MCSFR function in a system as close to physiological background before. A MCSFR-
deficient, GM-CSF-dependent BM-derived immortalized macrophage cell line has been used 
to characterize different MCSFR mutants (Yu et al. 2008). However, as these cells are in a 
mature stage, they were not suitable for our purpose of investigating M-CSF-mediated 
differentiation and lineage choice of uncommitted progenitor cells.  
 We noticed that reintroducing the wild type MCSFR into the MCSFR-deficient 
background did not rescue M-CSF-induced survival and differentiation to levels of 
endogenous MCSFR expression, although we sorted for endogenous MCSFR expression 
levels after transduction. Cell death triggered by stress through cell sorting and lentivral 
transduction per se can be mainly excluded as sorted ivGMPs carrying endogenous MCSFR 
and transduced with a Venus control virus survived and differentiated comparably to fresh 
BM-derived GMPs. One explanation might involve the lentivirus-mediated random 
integration of the MCSFR transgene, which is inherent to the viral transduction. The random 
insertion prevents genetic regulation by the endogenous MCSFR locus regulatory elements. 
Therefore, feedback mechanisms might fail to regulate MCSFR expression, which could be 
crucial for proper differentiation. Furthermore, there is a risk that the integrated promoter 
driving the MCSFR transgene is silenced during differentiation as is the case in other cell 
types (Herbst et al. 2012). This would lead to cells losing the receptor and therefore cell death 
due to lack of survival signals. Indeed, we often saw relatively late cell death events (data not 
shown), which is not the case in cells expressing endogenous MCSFR. The MCSFR antibody 
used for sorting transduced cells has been described to be blocking and to result in reduced 
and smaller colonies when used for sorting MCSFRpos MDPs and then culturing them in M-
CSF-containing medium (Auffray et al. 2009). However, sorting MCSFRpos ivGMPs derived 
from wild type animals did not have a detrimental effect on survival and differentiation in our 
hands and is therefore unlikely the cause for less differentiating cells in the rescue 
experiments. Of note, a recent study describing MCSFRpos monocyte-restricted progenitors 
used the MCSFR antibody for sorting and also did not report any detrimental effect 
(Hettinger et al. 2013). Despite reduced survival and differentiation compared to endogenous 
MCSFR expression, more than 50% of MCSFR-/- cells transduced with the MCSFR were 
rescued in their M-CSF-mediated differentiation to macrophages. This was sufficient to 
detect contributions of different tyrosine residues to this process.  
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7.2 Analysis of individual MCSFR tyrosine function 
 
 Former studies analyzing MCSFR tyrosine functions not only often relied on myeloid 
cell lines, but also used classical cellular assays to read out M-CSF-mediated effects on bulk 
cultures. Besides losing information on cell-to-cell variability, these assays can also obscure 
contributions of individual M-CSF-affected cell fates to an observed effect. Importantly, and 
in contrast to previous studies, we are able to simultaneously analyze individual cell fate 
parameters influenced by M-CSF at the single cell level by using live cell imaging. 
Therefore, our data can reveal, for example, if increasing cell number is due to modulated cell 
death frequencies, altered cell cycle times, or a combination of both. 
 Mutation of individual MCSFR tyrosines revealed varying effects on M-CSF- 
mediated cell survival, proliferation, and differentiation, indicating that each site 
differentially contributes to these responses. As previously described (Yu et al. 2008), 
mutation of all eight tyrosine residues results in a receptor incapable to transmit survival 
and/or differentiation signals, which we confirm to be the case in primary progenitors in this 
study.  
To look at contributions of individual tyrosines to progenitor proliferation and 
survival, we determined how many starting cells would at least make two consecutive cell 
divisions - after which cells are usually committed (Rieger et al. 2009) - or die before making 
a third consecutive division. Data from almost 2000 individually tracked colonies showed 
that none of the single MCSFR tyrosine mutations totally abrogated cell survival and 
proliferation, which corresponds to findings previously reported using mature macrophages 
(Yu et al. 2008). We find that mutation of Y706, Y721, and Y807 significantly compromised 
survival and proliferation, which is in line with previous studies in other cellular systems 
reporting proliferation defects if these sites are mutated (Takeshita et al. 2007, van der Geer 
& Hunter 1991, Yu et al. 2008). In our system, mutation of Y807 had the strongest defect on 
cell survival, which is also in line with a study conducted in mature macrophages, although 
the survival defect observed by Yu et al. was not as drastic (Yu et al. 2008). Individual 
mutation of Y559 or the remaining tyrosines did not have an effect on early proliferation or 
cell cycle times. This is somewhat surprising, as there are reports indicating a major role of 
Y559 in proliferation (Takeshita et al. 2007, Yu et al. 2008). However, these studies were 
done in a mature macrophage context, which divide infrequently (approximately every 24h). 
In contrast, the primary progenitors we used are highly proliferative, and it is possible that in 
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these cells, different pathways activated by different residues induce proliferation. Likewise, 
a hyperproliferative response to M-CSF when mutating Y559, as was reported for a myeloid 
cell line, was not observed in our model (Rohde et al. 2004). Surprisingly, cell cycle times, 
although being quite heterogeneous in general, were not greatly affected by mutation of 
single MCSFR tyrosine residues. 
 Individual mutation of Y559, Y721, and Y807 resulted in compromised M-CSF-
mediated macrophage differentiation. However, it is difficult to tell if decreased macrophage 
differentiation is due to a true differentiation defect, lack of survival, or a maturation defect. 
Moreover, it is not known if cells that have a block in differentiation would die or stay in an 
undifferentiated, proliferating state. For tyrosine residue Y807, which had a prominent effect 
on cell survival, we tackled this issue with a bcl2-overexpressing mouse model (Ogilvy et al. 
1999) crossed into the MCSFR-/- background. Cells of this background have prolonged 
survival in absence of cytokines due to the anti-apoptotic properties of bcl2. Indeed, we were 
able to rescue survival by that strategy independently of M-CSF and could confirm that Y807 
is also involved in M-CSF-mediated differentiation. However, due to complex mouse 
breedings, this strategy was so far not applied to other tyrosine residues involved in survival 
signaling. Worth mentioning, rescuing survival of cells transduced with the fully mutated 
receptor (YEF) by bcl2 overexpression did not restore M-CSF-induced proliferation and 
differentiation. This demonstrates that these M-CSF-mediated effects are indeed transmitted 
through the tyrosine residues studied here.  
A previous study using the myeloid progenitor cell line FDCP1 showed that mutation 
of Y807 abrogated M-CSF-induced differentiation and at the same time enhanced 
proliferation (Bourette et al. 1995). Although we can confirm the contribution of Y807 to 
differentiation, we do not detect hyperproliferation. The same study showed that Y721 was 
not required for differentiation. We also find that Y721 is not essential for differentiation, yet 
its mutation decreases the number of differentiating cells. Also in line with our results, 
mutation of Y559 has been previously linked to defects in M-CSF-induced differentiation of 
myeloid cell lines (Marks et al. 1999; Bourgin-Hierle et al. 2008).   
Strikingly, adding back Y559 to a fully mutated MCSFR background was sufficient to 
partially restore M-CSF-mediated survival, proliferation, and macrophage differentiation. 
This was further improved by additionally adding back Y807, rescuing survival and 
differentiation almost to Ywt levels and confirming the suggestion of previous studies that 
Y559 and Y807 play a central role in the major responses to M-CSF. In macrophages, 
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mutation of Y559 and Y807 significantly compromises M-CSF-dependent proliferation and 
maturation (Takeshita et al. 2007, Yu et al. 2008). In a later study, adding back only Y559 or 
Y807 was suficient to restore M-CSF-mediated survival but not maturation of macrophages, 
as determined via MacI expression (Yu et al. 2012). In contrast to Yu et al., adding back only 
Y807 was not suficient to restore survival in our system, nor could we confirm cytokine-
independent proliferation of cels rescued with Y807AB. Adding back only Y544, Y721, or 
Y807 partialy restored M-CSF-induced survival and proliferation, but was not suficient to 
rescue macrophage diferentiation, which is in line with what has been observed in 
macrophages (Yu et al. 2012). Interestingly, it has been shown that besides Y559 and Y807, 
Y544 is required to fuly restore receptor kinase activation and the capacity to proliferate in 
response to M-CSF (Yu et al. 2012). Thus, additionaly adding back Y544 to Y559 and Y807 
might improve M-CSF-induced survival and diferentiation in our rescue experiments even 
more. A summary of the diferent cel fates that have been linked to individual MCSFR 
tyrosine residues by mutation analysis in this study is depicted in Figure 7-1. 
 
 
Figure 7-1: Summary of the role of individual MCSFR tyrosine residues in M-CSF-mediated progenitor 
cel fates. 
Only significant results are summarized. Bold terms were most striking. 
 
In order to directly address the role of MCSFR tyrosine residues in lineage choice, we 
crossed the LysM:EGFP mouse model, in which EGFP is expressed once cels are commited 
to the M or G lineage, into the MCSFR-/- background. However, transplantation of W41 mice 
with LysM:EGFP x MCSFR-/- fetal liver cels never resulted in donor contribution, 
potentialy caused by the lack of lysozyme protein. However, as Y559 rescues macrophage 
diferentiation, it indicates that it is also suficient for M-CSF-mediated lineage instruction. It 
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would be interesting to assess how rescued MCSFR-/- progenitors would differentiate in vivo 
following transplantation and whether the monocyte/macrophage vs. granulocyte output 
would be shifted upon mutation of single tyrosine residues. However, in vivo, cells are 
exposed to a diversity of cytokines that can be functionally redundant and might mask altered 
signaling from a single receptor.    
 
 
 
7.3 M-CSF-induced SFK signaling is sufficient for macrophage differentiation 
 
Screening of individual MCSFR tyrosine residues revealed that Y559 was sufficient 
to rescue M-CSF-induced survival, proliferation, and differentiation. Y559 is the first 
tyrosine to be phosphorylated and has been proposed to be a switch residue, being critical for 
MCSFR kinase activity and receptor phosphorylation and at the same time activating a 
SFK/c-Cbl ubiquitination pathway that leads to full receptor activation on the one hand, and 
to ligand-induced receptor internalization and degradation on the other hand (Rohde et al. 
2004, Takeshita et al. 2007, Xiong et al. 2011, Yu et al. 2008). Several reports have described 
that Y559 is the only MCSFR SFK binding site in NIH3T3 fibroblasts and macrophages 
(Alonso et al. 1995, Courtneidge et al. 1993, Faccio et al. 2007). Other molecules binding 
Y559 have not been described. Interestingly, besides its role in receptor activation, Y807 has 
also been suggested to be involved in SFK activation (but not direct binding) (Courtneidge et 
al. 1993) and adding back Y807 together with Y559 improved M-CSF-elicited responses in 
our hands. Therefore, we reasoned that SFKs are sufficient to initiate and transmit M-CSF-
mediated actions. The fact that Y559 on its own is sufficient for M-CSF-mediated survival 
and differentiation but single mutation of Y559 does not have a drastic negative effect, 
indicates that further downstream signaling pathways activated via SFKs, can also (directly 
or indirectly) be activated through other MCSFR tyrosine residues.   
 SFKs are highly redundant cytoplasmic tyrosine kinases that initiate or modulate the 
response of many blood cells to extracellular stimuli. They often operate together with other 
cytoplasmic tyrosine kinases, such as Syk and those of the Tec family to activate further 
downstream signaling cascades (Lowell 2011). Classically, in immune cells carrying 
immunoreceptors (such as the T-cell/B-cell receptors or Fc receptors), SFKs phosphorylate 
immunoreceptor tyrosine-based activation motifs (ITAMs), which associate with the 
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activated receptor and function as docking sites for Syk. Activated Syk then phosphorylates 
downstream effectors, leading to activation of signaling pathways including PI3K/Akt and 
PLCγ signaling (Kurosaki et al. 2010, Smith-Garvin et al. 2009). SFKs also phosphorylate 
signal transduction proteins directly (e.g. focal adhesion kinase (FAK)) or other adaptor 
proteins (e.g. c-Cbl or Shc) that link SFKs to specific signaling molecules (e.g. PI3K or Ras, 
respectively) (Lowell 2011). Furthermore, SFKs can also elicit inhibitory signals in a similar 
fashion through phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIMs) 
(Munitz 2010). The SFK Lyn is primarily responsible for the phosphorylation of ITIMS, 
which then serve as docking sites for different types of phosphatases, such as SHP-1/2 or 
SHIP-1 (Scapini et al. 2009). Phosphatases then down-modulate signaling responses by 
dephosphorylating downstream substrates. SFKs also play important roles in pathways where 
ITAMs/Syk are not involved, as is the case for G-CSF and GM-CSF for instance. In these 
cases, SFKs have been found to be directly associated to the growth factor receptors 
(Perugini et al. 2010, Sampson et al. 2007). Due to the high functional redundancy of SFKs, 
approaches to study their isotype-specific functions are cumbersome. The study of SFKs is 
furthermore hampered by the unavailability of SFK member-specific phospho-antibodies. 
In line with our observation that Y559/SFK signaling is sufficient for M-CSF-
mediated effects, overexpression of constitutive active c-Src, but not SFK members Fyn, Lyn, 
and Hck, in wild type ivGMPs resulted in a marked shift of progenitor differentiation towards 
macrophages at the expense of granulocytes in permissive conditions. We did not observe 
cytokine-independent proliferation of cells transduced with constitutive active c-Src, arguing 
against a myeloid transformation-reflecting artifact. Inhibition of c-Src, or SFKs in general, 
via a dominant negative mutant of c-Src or the small molecule inhibitor SU6656, 
respectively, did not affect macrophage differentiation of wild type GMPs. This again 
indicates that pathways activated through c-Src can also be directly or indirectly activated 
through other, Y559/SFK-independent mechanisms. Of note, since SFKs are functionally 
highly redundant, targeting c-src alone with a dominant negative construct is probably 
compensated for by other SFKs. However, using a small molecule inhibitor against SFKs, we 
were able to block M-CSF-instructed macrophage differentiation of MCSFR-/- cells rescued 
with the Y559/807AB MCSFR. This demonstrates that the instructive signal can be 
transmitted through a SFK-dependent signaling axis. Unexpectedly, qPCR revealed that c-Src 
does not seem to be expressed in primary GMPs. The constitutive active c-Src might 
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therefore be phenocopying another SFK member, such as Fgr or Lck; two SFK members 
expressed in GMPs, but not studied further in this project.  
 In summary, our results indicate that MCSFR Y559/SFK-mediated signaling is 
sufficient for M-CSF-orchestrated macrophage differentiation. However, in wild type GMPs 
other MCSFR tyrosine residues and signaling pathways may be additionally involved.  
What lies downstream of SFKs? Upon M-CSF induction, SFKs have been reported to 
activate several major downstream signaling pathways, including MAPKs (ERK1/2 and p38), 
PI3K/Akt, PLCγ, and NFκB (Bourgin-Hierle et al. 2008, Lee & States 2000, Takeshita et al. 
2007, Wang et al. 2012a, Yu et al. 2012). SFKs have also been described to have a negative 
regulatory role in M-CSF signaling by downregulating PI3K/Akt activity through recruitment 
of the phosphatase SHIP-1 (Baran et al. 2003). Recently, it was found that M-CSF-activated 
SFKs can also signal via ITAM-containing adaptor protein DAP12 in osteoclasts and 
macrophages, similar to classic SFK signaling involving immunoreceptors (Otero et al. 2009, 
Zou et al. 2008). This suggests that M-CSF-mediated SFK activation may act through Syk 
and/or possibly other kinases, such as those of the Tec family (Melcher et al. 2008). Of note, 
both M- and G-CSF led to upregulation of DAP12 as detected by microarray analysis. Our 
microarray data further suggests that Syk signaling is among the most prevalent pathways 
activated upon M-CSF stimulation, with most Syk-associated genes being upregulated shortly 
after lineage commitment.  
Overexpression of constitutive active Akt, although not as pronounced as compared to 
c-Src, also led to an increased macrophage output, while inhibiting PI3K/Akt via a small 
molecule reduced macrophage differentiation. Moreover, mutation of Y721, the major 
MCSFR residue mediating direct PI3K/Akt activation, led to a decrease in macrophage 
differentiation. Noteworthy, in mice, constitutive active Akt has been shown to induce 
myeloid expansion in the spleen in vivo and was suggested to play a role in human myeloid 
lineage decisions (Buitenhuis 2008, Kharas et al. 2010). Interestingly, overexpression of p65 
also resulted in a strong increase in macrophage output at the expense of granulocytes. 
Activation of the NFκB pathway by Akt is well described (Dan et al. 2008, Madrid et al. 
2001). In response to M-CSF, it has also been suggested that p65 is directly activated via 
PKC (Wang et al. 2011). 
Collectively, our results suggest that M-CSF-instructed differentiation of GMPs to 
macrophages can occur through SFK-activated signaling, possibly involving downstream 
activation of Syk, PI3K, and/or NFκB signaling (Figure 7-2). However, it is not clear whether 
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such a mechanism alone regulates M-CSF diferentiation signaling. Other pathways 
downstream of SFKs may also be involved and might further be activated through other 
tyrosine residues independently of SFKs. These include, for example, MAPK or PLCγ/PKC 
signaling. Indeed, studies associating loss of Y559/SFK signaling with M-CSF-mediated 
diferentiation of myeloid cel lines and BM cels suggested involvement of STATs and 
PLCγ/MAPK signaling downstream of SFKs (Bourgin-Hierle et al. 2008, Marks et al. 1999). 
Mice deficient for individual SFKs do not show obvious phenotypes in general, 
demonstrating that there is substantial functional overlap among the diferent SFKs. 
Macrophage development in mice lacking single or multiple SFK members is normal (Hibbs 
et al. 1995, Lowel et al. 1994, 1996). Interestingly, c-Src-deficient mice, similar to M-CSF- 
deficient mice, develop severe osteopetrosis due to malfunctioning osteoclasts (Soriano et al. 
1991). However, this seems to be independent of the kinase function of c-Src (Schwartzberg 
et al. 1997). Nevertheless, it would be interesting to analyze whether SFK-deficient GMPs 
would stil diferentiate normaly upon M-CSF exposure in vitro and whether GM progenitor 
cels expressing a constitutive active c-Src would also produce more monocytes/macrophage 
upon transplantation and exposure to in vivo conditions. 
 
 
 
Figure 7-2: Proposed minimal M-CSF-triggered signaling suficient for macrophage lineage instruction 
and diferentiation. 
Our results demonstrate that Y559/SFK signaling is sufficient for M-CSF-mediated lineage instruction and 
diferentiation. Downstream of SFKs our results suggest involvement of PI3K/Akt and/or p65 (NFκB) 
signaling. However, we cannot exclude involvement of additional signaling pathways such as ERK (MAPK) 
signaling. 
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7.4 M- and G-CSF signaling are highly overlapping 
 
 The receptors for M-CSF and G-CSF are fundamentaly diferent and belong to 
diferent receptor classes. Nevertheless, both receptors activate a common set of downstream 
signaling pathways inducing proliferation and diferentiation to produce distinct lineages 
from the same progenitor cels. Among the shared signaling components are SFKs, 
PI3K/Akt, and MAPKs. One possibility how the same signaling pathway could lead to 
diferent lineage outputs from a common progenitor population might be through activation 
strength and duration (Figure 7-3). It has been suggested that persistent and potent MAPK 
activation is required for M-CSF-mediated macrophage diferentiation and that reduced 
MAPK signaling leads to granulocytic diferentiation (Bourgin-Hierle et al. 2008, Gobert 
Gosse et al. 2005, Jack et al. 2009). One explanation why overexpression of constitutive 
active c-Src resulted in enhanced macrophage differentiation at the expense of granulocytes 
might therefore be the strong and persistent activation of a downstream signaling pathway, 
such as PI3K, NFκB, or MAPK. 
 
 
Figure 7-3: M- and G-CSF signaling extensively overlaps. 
Although being two different types of receptors, MCSFR and GCSFR activate common signaling pathways to 
produce cels of diferent lineages. The diferent outcomes might be explained by different duration or strength 
of signaling activity (indicated by the bold vs. thin arrow).  
 
 To address how signaling strength and length affect lineage outcome, methods are 
required that alow continuous detection and quantification of signaling activity in primary 
HSPCs. The low number of available primary progenitors renders the use of classical 
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biochemical approaches (e.g. Western blot or flow cytometry) to investigate activation of 
signaling pathways impractical or impossible. Furthermore, these methodologies are static 
and do not allow investigating relationships between current molecular state and future cell 
fates. Therefore, combining live cell imaging with sensors of signaling activity could link 
strength and length of signaling to future cell fates, which would help to understand above 
mentioned differentiation mechanisms (Endele & Schroeder 2012).  
 In this study, we show that the application of biosensors in primary myeloid cells is 
principally feasible by demonstrating PI3K signaling activation in single live GMPs using a 
translocation-based sensor. Biosensors based on translocation-events are particularly useful to 
get insight into signaling dynamics. Due to the wide range of fluorescent hues, multiple 
pathway activations can be monitored within a single cell using different biosensors 
simultaneously. Other sensors are based on FRET. These sensors harbor a specific substrate 
whose modification by the molecule of interest (e.g. a kinase or GTPase) results in a 
conformational change and FRET, thereby visualizing protein activity. Moreover, as they are 
genetically encoded, FRET-based sensors can be targeted to distinct intracellular 
compartments via specific genetic localization sequences, allowing to measure signaling 
activity from functionally distinct organelles within the cell. This has provided insight into 
how intracellular compartmentalization can affect signaling (Gallegos et al. 2006, Kajimoto 
et al. 2010). Our effort to integrate FRET-based biosensors into lentiviruses as a mean to 
transduce difficult-to-transfect HSPCs never resulted in viral particles harboring the correct 
sensors (data not shown). This was most likely due to the high sequence similarity of the 
genes for CFP and YFP typically used as FRET pairs in these sensors, leading to homologous 
recombination during reverse transcription in the production of lentivirus. Novel fluorescent 
proteins without sequence similarities to the GFP family of fluorescent proteins could help to 
overcome this issue.    
 Despite their advantages over classical biochemistry, biosensors have some caveats 
that need to be carefully considered. Most importantly, it has to be ensured that cellular 
physiology is not disrupted through potential competition of the sensor with natural 
intracellular ligands. To avoid this, the strength of biosensor expression should not exceed 
levels of endogenous products, while simultaneously being high enough to reliably detect it. 
Another issue is phototoxicity. Detecting highly dynamic intracellular processes often 
requires a temporal resolution (i.e. imaging frequency) in the seconds to minutes range. To 
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minimize phototoxic effects, fluorescent proteins with longer excitation wavelengths and thus 
lower energy are preferred over ones excited by blue or near-ultraviolet wavelengths.  
 In conclusion, combining long-term single cell imaging with the detection of live 
signaling activity through biosensors could help identifying the individual roles of cytokine-
triggered signaling cascades in controlling HSPC fates.  
 
 
 
7.5 M- and G-CSF-induced gene expression 
 
 To learn about differences in the response of primary progenitor cells to M- and G-
CSF-stimulation we carried out microarray analysis. Considering the fact that many signaling 
pathways are shared by M- and G-CSF, it might not be surprising that the overall gene 
expression induced by M- and G-CSF was relatively similar. Even genes associated with 
macrophage differentiation were upregulated by G-CSF stimulation, such as the genes for 
macrophage markers F4/80 or MCSFR. This does not necessarily mean that all these genes 
are ultimately translated into protein, as has been known for many years (Jack & Fearon 
1988). However, there have also been reports demonstrating that terminally differentiated 
neutrophils can be transdifferentiated into macrophages by M-CSF and other cytokines, 
suggesting that they do functionally express the MCSFR (Araki et al. 2004, Sasmono et al. 
2007).  
Due to the high overlap of gene expression changes upon M- and G-CSF stimulation 
but the higher number of G-CSF-specific genes (that are not regulated by M-CSF), it is 
tempting to speculate that macrophages are the default myeloid cell type and that 
granulocytes arise through induction of a few additional lineage-determining genes, as has 
been suggested before (Sasmono et al. 2007). Such genes might be the ones for transcription 
factors Id2 and STAT3, which in our microarray were specifically upregulated by G-CSF and 
not M-CSF. Indeed, it has been shown in previous studies that inhibition of Id2 expression 
blocks differentiation to granulocytes (Buitenhuis et al. 2005). Furthermore, STATs are 
extensively described to be involved in G-CSF signaling. However, expression of constitutive 
active STAT3 in ivGMPs did not seem to have an effect on granulocyte output in our hands, 
which is in line with the generation of functional granulocytes in STAT3 knockout mice (Lee 
et al. 2002). 
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7.6 Outlook 
 
 Tightly controlled lineage decisions are essential for steady-state hematopoiesis and 
their perturbation can lead to severe blood disorders and leukemia. Therefore, understanding 
the molecular mechanisms underlying hematopoietic lineage choices is of high clinical 
interest and could lead to applications aiming at manipulating lineage decisions in order to 
enhance lineages that are diminished due to disease. In this study, we show that M-CSF-
mediated lineage instruction of GMPs towards macrophages can be transmitted via a SFK-
initiated signaling axis. It remains to be identified, which exact signaling pathways activated 
downstream of SFKs are involved in propagating the lineage-instructive signal. Our results 
suggest PI3K and/or NFκB signaling as possible mediators downstream of SFKs. Similarly, 
transcription factors involved in ultimately carrying out lineage commitment by activating 
lineage-specific gene expression remain to be elucidated. Finally, whether M-CSF and G-
CSF utilize differential or same signaling axes to instruct different lineage choices from the 
same progenitor is still unknown. Early target gene expression in GMPs was very similar 
between M- and G-CSF stimulation, suggesting that at least the initially activated signaling 
pathways are shared. How same signaling pathways activated by two different stimuli lead to 
two different lineages could be resolved using fluorescent biosensors that allow the 
quantification of signaling dynamics and kinetics in single living cells.  
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8 Appendix 
 
       Table 8-1: GO term analysis of M-CSF time series clusters 
Pattern 
(M-CSF) 
GO terms                                   
(top 3) 
p-value   
(Benjamini) 
 
I 
immune response 
regulation NFκB cascade 
chemotaxis 
 
2,5E-5 
1,8E-3 
1,6E-2 
 
 
II 
sterol biosynthetic process 
cholesterol biosynthetic process 
sterol metabolic process 
 
9,8E-11 
1,2E-9 
1,4E-9 
 
 
III 
 
cellular protein catabolic process 
macromolecule catabolic process 
proteolysis 
 
6,2E-5 
7,5E-5 
9,0E-5 
 
 
IV 
cell cycle 
mRNA metabolic process 
RNA processing 
 
2,8E-4 
3,1E-3 
3,7E-3 
 
 
V 
DNA metabolic process 
RNA processing 
DNA replication 
 
6,1E-11 
2,9E-9 
2,0E-7 
 
 
VI 
transcription 
regulation of transcription 
 
5,3E-5 
1,9E-2 
 
 
VII 
cofactor metabolic process 
coenzyme metabolic process 
transcription 
 
1,1E-3 
2,1E-3 
4,5E-2 
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                    Table 8-2: GO term analysis of G-CSF time series clusters 
 
Pattern 
(G-CSF) 
GO terms                                                     
(top 3) 
p-value   
(Benjamini) 
 
I 
immune response 
regulation of cell death 
regulation of programmed cell death 
 
6,8E-5 
4,7E-4 
5,3E-4 
 
 
II 
immune response 
regulation of actin polymerization 
regulation of actin filament length 
 
1,6E-6 
3,2E-4 
2,6E-4 
 
 
III 
 
sterol biosynthetic process 
cholesterol biosynthetic process 
steroid biosynthetic process 
 
1,4E-7 
2,1E-7 
1,2E-5 
 
 
IV 
DNA packaging 
nucleosome assembly 
cellular macromolecular complex assembly 
 
2,1E-7 
7,8E-7 
5,7E-7 
 
 
V 
ribonucleoprotein biogenesis 
ribosome biogenesis 
RNA processing 
 
3,2E-13 
7,1E-12 
2,7E-11 
 
 
VI 
DNA metabolic process 
RNA processing 
ncRNA metabolic process 
 
1,2E-14 
1,8E-10 
3,3E-10 
 
 
VII 
transcription 
regulation of transcription 
negative regulation of macromolecule 
biosynthetic process 
 
3,8E-4 
6,6E-3 
4,4E-2 
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Table 8-3: List of acquired translocation-based biosensors for signaling activation 
 
Biosensor Detection     Reference   
            
  
PH-Akt  PI(3,4)P2 and PI(3,4,5)P3, PI3K activation (Haugh et al. 2000)   
PLCδ-PH PI(4,5)P2 and IP3, PLC activation  (Stauffer et al. 1998)   
PKCγ-C1 DAG, PLC activation    (Oancea et al. 1998)  
p65-GFP NFκB activation     (Tay et al. 2010) 
PKC-RFP PKC activation     (Kajimoto et al. 2010)  
 
 
 
Table 8-4: List of acquired FRET-based biosensors for signaling activity 
 
Biosensor Detection  Reference      
            
  
Raichu-cdc42 cdc42 activity  (Itoh et al. 2002) 
Raichu-RhoA RhoA activity  (Yoshizaki et al. 2003) 
Akind  Akt activity  (Yoshizaki et al. 2007) 
Miu2  ERK2 MAPK  (Fujioka et al. 2006)  
CKAR  PKC activity  (Violin et al. 2003) 
KCP-1  PKC activity  (Schleifenbaum et al. 2004)     
KCAP-1 PKA, PKC  (Brumbaugh et al. 2006) 
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